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 ABSTRACT   
 
Diagnosing diseases in wildlife is challenging, the availability of diagnostic tests 
that perform at the same level of sensitivity and specificity in wild animals as 
their human and livestock counterparts is limited. In the last few decades 
increased awareness of the role of wild animals in the maintenance and spread 
of important zoonotic infections means that research has been directed into 
development of specific diagnostic tests aimed at wildlife that can be used for 
research, surveillance and wildlife control programmes.    
Wild animals are subject to a wide range of genetic and environmental factors 
many of which may influence their immune response. These additional 
pressures may affect the immune system in different ways and within a group of 
animals; individuals will vary. The first aim of this dissertation was to investigate 
variation in the cell-mediated immune (CMI) response of free-living badgers to a 
range of intrinsic factors. Results revealed factors that may suppress the non-
specific immune response such as old age, presence of wounds and larger 
social group sizes and those that amplify the specific M. bovis response such as 
age, presence of wounds and bTB exposure. Results also showed complex 
interactions between body condition with age, sex and season which influenced 
both the specific and non-specific CMI response. Second, to aid in disease 
surveillance and management, we developed and evaluated a technique to 
collect and test blood from unanaesthetised badgers in the field. This study 
successfully demonstrated proof of concept where a method of capillary blood 
collection used in the field enabled the operator to carry out a rapid diagnostic 
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test for the presence of Mycobacterium bovis infection. In addition we have 
shown that the accuracy of the DPP VetTB test carried out in the controlled 
conditions of the laboratory cannot be replicated when testing under field 
conditions suggesting that stochastic conditions in the field may affect TB 
diagnostic outcomes.   
My findings illustrate the importance of understanding variation in test 
performance, arising from intrinsic and extrinsic factors in diagnosing and 
managing bovine tuberculosis in badgers, and other diseases of highly variable 
wild hosts.  
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CHAPTER 1 Introduction to Wildlife Diseases 
 
Disease can, in its broadest sense, be regarded as anything that causes 
impairment of the normal function of a living organism (Delahay et al., 2009). 
Infectious disease refers to the ability of parasites or pathogens to go through 
the process of entering another organism, replicating and causing harm (Ross, 
1983).  These parasites/pathogens have been divided into two broad 
categories, the macroparasites and microparasites, based, to some extent on 
their size, but primarily on their mode of replication, population biology and the 
nature of their interaction with the host (Anderson, 1982).  Macroparasites 
include helminths and arthropods and are more commonly associated with 
more chronic infections. Macroparasites are typically larger than microparasites 
and immunity is of short duration in heavily infected hosts resulting in infections 
that are persistent and where reinfection is common (Wobeser, 2002). 
Microparasites include bacteria, viruses, fungi and protozoa and are frequently 
associated with acute disease. Microparasites have a short generation time and 
usually multiply rapidly within the host; hosts that recover from infection usually 
have long-lived immunity that protects against re-infection (Delahay et al., 
2009).   
In recent decades infectious pathogens found in wild animal species have 
become increasingly important in infectious disease research with particular 
interest in diseases that have a substantial impact on human health, agricultural 
production, biodiversity, animal welfare and the economy (Bengis et al., 2004). 
Some pathogens cause significant disease in their wildlife host and can have an 
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effect on their behaviour, fecundity, growth or metabolic requirements and in 
some cases cause death, whilst others may not induce overt illness in the host 
but instead lead to the host becoming a reservoir for the pathogen (Williams et 
al., 2002), the importance of understanding this role as reservoir is becoming 
more widely appreciated (Simpson, 2002).  
Human activities including concurrent human and domestic animal population 
expansion and encroachment into wildlife habitat, international movement of 
livestock and modern agricultural practices, introduction of domestic and wild 
animals into new habitats (Daszak et al., 2001) along with environmental 
change are resulting in new infectious disease dynamics and patterns 
favourable to pathogens spreading both geographically and between species as 
well as new opportunities for increasing genetic variability (Howard and 
Fletcher, 2012). The increasing emergence of disease in wildlife populations 
may be a natural phenomenon or anthropogenically driven and in some cases 
there may be severe consequences for wildlife populations. Examples of such 
cases include the Chytrid fungus (Batrachochytrium dendrobatidis) which has 
been linked to dramatic population declines and extinction in some species of 
amphibian over several continents (Stuart et al., 2004), white-nose syndrome 
associated with high mortality in bat species in the Northern US (Blehert et al., 
2009) and Devil facial tumour disease causing a decline in Tasmanian devil 
(Sarcophilus harrisii) populations (McCallum, 2008).   
Wildlife also plays a major role in disease transmission and this should be taken 
into consideration when addressing certain diseases in domestic livestock and 
humans. Infectious diseases that can be transmitted from animals to humans 
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are referred to as zoonotic. A study by Jones et al. (2008) found that 60% of 
emerging infectious disease (EID) events in humans were caused by zoonotic 
pathogens, of which 72% were from a wildlife origin. Humans can be infected by 
diseases carried by wildlife both directly and indirectly through vectors such as 
ticks and mosquitoes. In some wildlife diseases, transmission of the pathogen 
to humans is a rare event but once it has occurred human to human 
transmission maintains infection within the population. Examples of such cases 
include human immunodeficiency virus (HIV), Ebola, influenza A and severe 
acute respiratory syndrome (SARS) (Bengis et al., 2004). Other infectious 
pathogens may transmit to humans from animals but are not generally 
transmitted from person to person. For example, the arenavirus haemorrhagic 
fevers, Hantavirus pulmonary syndrome and Nipah virus (Morens et al., 2004). 
Diseases found in both wild and domestic animals have two major implications, 
economic impact due to the effect of disease on the domestic species itself and 
the risk the diseases pose to human health. The 2001 foot and mouth disease 
outbreak is said to have cost the UK around £3.1 billion in losses to agriculture 
and the food chain (Thompson et al., 2002) and the bluetongue serotype 8 
epidemics of 2006 and 2007 in the Netherlands had an estimated net cost of 
32.4 million Euros in 2006 and between 164 and 175 million Euros in 2007 
(Velthuis et al., 2010).  
Bovine tuberculosis (bTB) is among the most important zoonotic diseases at the 
livestock-wildlife interface and has a significant impact on human health and the 
economy (Krebs, 1997; Michel et al., 2010). Mycobacterium bovis is the 
causative agent of bTB. M. bovis is of public health concern especially in 
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developing countries due to its zoonotic potential (Cosivi et al., 1998; Theon, 
2006). M. bovis infection in badgers (Meles meles) in the UK (Clifton-Hadley et 
al., 1993) and Republic of Ireland (Gormley and Collins, 2000) is a major source 
of infection in cattle. M. bovis infection causes similar problems in other wildlife 
species around the world including the brushtail possum (Trichosurus 
vulpecula) in New Zealand (Coleman and Cooke, 2001), white-tailed deer 
(Odocoileus virginianus) in the United States (Schmitt et al., 1997), European 
wild boar (Sus scrofa) in Spain (Naranjo et al., 2008) and African buffalo 
(Syncerus caffer) in Africa (Vos et al., 2001).   
With the increasing knowledge that wildlife species can act as a reservoir of 
diseases transmissible to humans and domestic animals there is a growing 
interest in developing methods to control transmission. Control measures have 
included setting up barriers, hygienic measures, habitat management, vector 
control, treatments, fertility control, culling, vaccination and test-and-slaughter 
policies  (Wobeser, 2002; Artois, 2003; Killian et al., 2007; Bengis et al., 2002). 
In some cases some of these control methods may be impractical or difficult to 
carry out and culturally or morally unacceptable in wildlife populations (Bengis, 
2002).  
In the case of bTB in the UK various control options have been considered to try 
and prevent spread between badgers and livestock. From 1973 until 1997 
(Krebs et al., 1997), and again since 2011 (DEFRA, 2011) the nonselective 
culling of badgers has formed part of bTB control policy in the UK. However this 
control strategy has been unpopular with the British public. In consideration of 
animal welfare and the unpopularity of culling, vaccination may be an alternative 
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or additional option. Badgers could be vaccinated against M. bovis infection with 
the aim to reduce spread amongst badgers and to other animals (Buddle et al., 
2000; Chambers et al., 2011; Carter et al., 2012) and with access to a suitable 
diagnostic test that could be used at trap-side, a test vaccinate/remove (TVR) 
programme might be a more attractive option and possibly more publicly 
acceptable (Bielby et al., 2014).  
Testing for disease in wildlife is usually more difficult than in domestic animals. 
Wild animals are free-living and therefore not constrained by barriers and can 
range over large areas (Mörner et al., 2002). This makes them more difficult to 
access compared to domestic stock so identifying signs of disease and 
diagnosis can be more challenging and expensive. For the majority of diseases 
found in both wildlife and domestic animals, assessments of the sensitivity and 
specificity of a diagnostic test have been based on the domestic species. 
Sensitivity and specificity of a test can vary considerably due to differences in 
pathogenic strains and serovars, host serological responses, and exposure to 
organisms of similar antigenic structure that produce cross-reacting antibodies 
(Gardner et at., 1996). In addition individual wild animals are inherently more 
variable than livestock, and to some extent humans, in that they experience a 
wider range of conditions. Thus diagnosis in wild animals interacts markedly 
with between-individual variation in state/condition. With this in mind the test 
cannot be assumed to have the same accuracy in its wildlife counterpart 
(Bengis et al., 2002).  The availability of diagnostic assays is a pivotal issue 
when managing bTB in wildlife. Many of the tests available have been 
developed for use in domestic animals and humans and therefore the sensitivity 
and specificity are unlikely to be the same.  
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Recognition of the role that some wildlife species have as a maintenance host 
that could cause a spill-over of disease to other species has led to more 
focused studies with development of M. bovis diagnostic tests in a variety of 
wildlife species (Chambers, 2013; Maas et al. 2013). Three diagnostic tests are 
used routinely in studies of badgers and include culture (Gallagher and Horwill, 
1977), StatPak serological assay (Chambers et al. 2008) (recently discontinued 
by the manufacturer and superseded by the dual path platform VetTB assay, 
Chembio, Medford, NY, USA, currently under evaluation in badgers) and the 
interferon-gamma enzyme linked immunosorbent assay (IFNᵧ ELISA) (Dalley et 
al., 2008). Bacterial culture of a range of clinical samples including faeces, 
urine, tracheal aspirate and bite wounds requires the animal to be 
anaesthetised for collection. Culture has a low sensitivity of around 8% (Drewe 
et al., 2010) and can take up to 8 weeks for results with specialist laboratory 
equipment required. The StatPak and VetTB assays require a blood sample 
that is taken under anaesthetic however due to the small quantity required for 
the VetTB assay (10 µl) it has the potential as a trap-side test. Results are rapid 
(20 minutes from application) and no specialised laboratory equipment is 
required. The StatPak assay has only moderate sensitivity of 50.4% (Drewe et 
al., 2010) and the sensitivity of the VetTB is yet to be determined. The IFNᵧ 
ELISA measures the cell-mediated immune response, based on measures of 
IFNᵧ released in response to specific mycobacterial antigens PPD B and PPD 
A. This more sensitive assay (80.9%) requires blood taken under anaesthesia 
to be processed within 7 hours (Dalley et al., 2008). Results are available in 
48hrs though the test requires specialist laboratory equipment. The IFNᵧ ELISA 
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has the added advantage of incorporating assay of the response to a non-
specific immune stimulant pokeweed mitogen (PWM) as a positive control.  
In Chapter 2 of this thesis, I investigate variation among a wild population in 
their IFNᵧ responses to both the specific (PPD A and PPD B) and non-specific 
(PWM) immune stimulants. My aim is to investigate the influence of a range of 
intrinsic factors on the magnitude of badgers’ cell-mediated immune responses. 
Monitoring of M. bovis infection in live badgers is currently carried out by taking 
various samples from badgers that have been trapped and anaesthetised. For a 
selective control programme to be feasible, a more efficient way to test badgers 
would be required. In Chapter 3 I investigate a blood collection technique on 
unanaesthetised badgers at trap-side where wild badgers were kept in traps for 
a relatively short period, during which a small blood sample was taken and a 
serological test carried out. My aim is to develop a repeatable method for 
capillary blood collection which can be used in the field to test for the presence 
of Mycobacterium bovis infection in badgers.  
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CHAPTER 2  Variation in the interferon-gamma response of wild badgers 
Meles meles 
 
2.1 Abstract 
In the UK and Ireland, European badgers (Meles meles) are an important 
wildlife reservoir of Mycobacterium bovis, the causative agent of bovine 
tuberculosis. An important component for development of strategies to control 
M.bovis in badgers involves accurate diagnosis of infection in the live animal for 
which there are various diagnostic tests available. There are, however, 
limitations with these tests especially when used in isolation from other clinical 
information. Host-pathogen interaction in tuberculosis infections is a complex 
process and the cell-mediated immune response has been observed in other 
species as the dominant response at early stages of anti-microbial immunity. 
The gamma interferon (IFNᵧ) enzyme linked immunoassay (ELISA) has been 
developed to detect the cytokine IFNᵧ an important component of the cell-
mediated immune response. IFNᵧ production is critical in determining the 
effectiveness of the immune response to intracellular pathogens such as M. 
bovis. Various intrinsic factors may affect the level of IFNᵧ produced to both 
specific and non-specific immune stimulants. This study investigates a number 
of intrinsic factors to determine if they have an influence on the cell-mediated 
immune response of badgers. The results show that age, season, year, body 
condition, wounds, exposure to Mycobacterium bovis (bTB exposure), group 
size and various interactions with body condition including age, sex and season 
significantly influence the immune response of badgers either specifically in 
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response to PPD A and PPD B tuberculin or non-specifically to PWM, or both. 
This study has revealed factors that may suppress the non-specific immune 
response such as old age, presence of wounds and larger social group sizes 
and those that augment the specific M. bovis response such as age, presence 
of wounds and bTB exposure. Year and season appear to be common factors 
for both with a drop in IFNᵧ levels over the study period with the highest levels 
apparent during winter. These results provide insights into potential 
determinants of susceptibility to infection and detection of infection in badgers, 
through suppression and enhancement of non-specific and specific immune 
responses.   
Keywords: Mycobacterium bovis; gamma interferon; intrinsic factors; cell-
mediated immune response 
 
2.2 Introduction 
Bovine tuberculosis (bTB) is an infectious, zoonotic disease that causes a 
significant economic burden and financial loss to taxpayers and the livestock 
industry. Bovine TB is endemic in many countries (Schiller et al., 2010) and 
since the early 1990s the UK has seen a rapid increase in the incidence of bTB 
in cattle (Godfray et al., 2013). The causative agent of this disease is the 
intracellular acid-fast bacterium Mycobacterium bovis. It was first suggested that 
the European badger (Meles meles) was a source of infection for cattle in the 
1970s (Muirhead et al., 1974) and badgers are still the principal wildlife species 
implicated in bTB epidemiology in the UK and Ireland. 
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The host-pathogen interaction in tuberculosis infections is a complex process 
(Boom, 1996; Pollock et al., 2001). The cell-mediated immune response has 
been observed in other species as the dominant immune response at early 
stages of anti-microbial immunity (Griffin et al., 1991; Gutierrez et al., 1998; 
Ritacco et al., 1991). A study by Cassidy et al (2001) has shown that in cattle T-
cells are among the first cells involved at the site of infection with M. bovis. 
Cattle infected experimentally with M. bovis have shown that the CD4+ memory 
T-cells appear to be the dominant cells producing interferon gamma (IFNᵧ) with 
CD8+ memory T-cells also producing IFNᵧ (Hope et al., 2000). IFNᵧ production 
is critical in determining the effectiveness of the immune response to 
intracellular pathogens (Frucht et al., 2001) and has been shown to modulate 
the immune response to a variety of intracellular pathogens, including M. 
tuberculosis (Flynn et al., 1993). M. bovis can survive within the macrophage 
(Aldwell et al., 2001) and IFNᵧ is thought to be critically involved in the immune 
response due to its major role in macrophage activation, inducing the release of 
mycobactericidal nitric oxide (Bonecini-Almeida et al., 1998; Flynn et al., 1993). 
Stimulation of the memory T-cell response with mycobacterial antigens 
therefore provides a means to detect M. bovis infection (Pollock et al., 1996) as 
IFNᵧ can be released in vitro and then quantified by means of an enzyme linked 
immunosorbant assay (ELISA).  
Many wildlife species are exposed to environmental mycobacteria (Stainsby et 
al., 1989). Balseiro et al. (2002) provided evidence of environmental 
mycobacteria Mycobacterium avium complex (MAC) in badgers in the UK which 
they attributed to badgers’ lifestyle of digging, living underground and broad 
diet, including earthworms and other invertebrates (Neal and Cheeseman, 
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1996). Infection by environmental mycobacteria can result in high levels of IFNᵧ 
production in vitro from lymphocytes stimulated with bovine tuberculin, due to 
the presence of antigens common to both mycobacterial strains. In non-infected 
animals, potential cross-reactions can lead to false-positive diagnoses. Where 
this occurs, comparison with responses to avian tuberculin is often used to 
facilitate discrimination between cattle infected with M. bovis and those exposed 
to environmental strains (Pollock et al., 2005). It has also been shown in 
experiments with guinea pigs that prior exposure to environmental mycobacteria 
can have a modulatory effect on the protective efficacy of the Bacille Calmette-
Guérin (BCG) vaccine due to shared mycobacterial antigens present (Kamala et 
al., 1996). Exposure to these environmental mycobacteria may therefore also 
contribute to the immune response by acting as immunomodulators due to 
common/cross-reacting antigens between M. bovis and MAC species.   
An important component of strategies to control M. bovis in cattle and badgers 
involves accurate diagnosis of infection in the live animal. There are various 
diagnostic tests available, with differing levels of performance in identifying 
infected badgers. Although culture of tissues obtained post mortem is 
considered to be a ‘gold standard’, culture has relatively low sensitivity when 
applied to clinical samples due partly to the intermittent excretion of detectable 
levels of bacteria (Chambers et al., 2002; Gavier-Widen et al., 2001; Neill et al., 
1988).  Alternative in vitro diagnostic tests include serological assays, such as 
the Brock StatPak assay (Chambers et al., 2008) drawbacks of which include 
cross-reactivity with other environmental bacteria (Stainsby et al., 1993) and 
potential delays in seroconversion (Hanna and Neill, 1992).  
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Diagnostic tests that detect early stages of infection (Pollock and Neill, 2002; 
Vordermeier et al., 2002) are based on measurement of the cell-mediated 
immune response and have been found to be more sensitive (Wood, et al., 
1992). The interferon gamma enzyme-linked immunosorbant assay (IFNᵧ 
ELISA) is one such test. In this test, sampled lymphocytes are stimulated 
overnight with bovine tuberculin, which is a purified protein derivative of M. 
bovis (PPD B) and the subsequent plasma harvested from this is tested for the 
presence of gamma interferon released in response to M. bovis infection by the 
IFNᵧ ELISA (Dalley et al., 2008). PPD B tuberculin is prepared by precipitation 
of heat-killed cultures of M. bovis and contains a poorly defined mixture of 
antigens (Paterson, 1948). Prior exposure to environmental mycobacteria may 
cause a cross-reaction, as demonstrated in studies of cattle (Aagaard et al., 
2010; Schiller et al., 2010).  Addition of an avian tuberculin, purified protein 
derivative (PPD A), used alongside PPD B reduces the likelihood of false 
positive results due to environmental mycobacteria, as a positive result is based 
on the optical density of the PPD B response minus the optical density of the 
PPD A response.  
In badgers M. bovis may persist in a clinically latent state, potentially creating a 
population of ‘silent’ M. bovis, which can reactivate later in life and represent a 
major source of disease (Gallagher and Clifton-Hadley, 2000). Infection in 
badgers is complex; some animals appear capable of containing the infection 
without showing clinical or pathological signs, though they intermittently excrete 
bacilli. A study by Gallagher et al (1998) observed pale/partially stained acid 
fast bacilli, typical of dead/inactive mycobacteria, in microscopic lesions in 
badgers considered to be not visibly lesioned (NVL) at post-mortem. Given that 
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some lesions were also free of bacilli, the author suggested this may indicate 
the resolution of infection with maintenance of a memory T-cell response.   
Mitogens such as phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) 
have been used in many studies to investigate the ability of lymphocytes to 
proliferate, and as an indicator of cell viability (Lesellier et al., 2008). Such 
nonspecific stimulants of lymphocytes reveal the more generalised immune 
function and response of T-cells to a wide range of pathogens and not just 
exposure to antigen-specific ones (Jackson et al., 2011). 
Across most of the UK, badgers are group living and aerosol exposure to M. 
bovis is considered to be the most frequent route of infection, with the lungs and 
the associated lymph nodes as the primary site of infection (Gallagher et al., 
1976). Excretion of M. bovis may occur in sputum, faeces, urine, and wound 
exudate (Gallagher and Clifton-Hadley, 2000). Badgers have a fossorial 
lifestyle, complex social group structure and exhibit territorial aggression, all of 
which may influence transmission of infection. Although various intrinsic factors 
may be expected to affect the magnitude and character of cell-mediated 
immune responses in infected badgers, detailed studies are scarce. The aim of 
this study is to investigate the potential effects of intrinsic factors such as sex, 
age, bite wounds, body condition, social group size, season, year and variation 
in exposure to M. bovis (bTB exposure), on the magnitude of multiple IFNᵧ 
responses in badgers (i.e. antigen specific PPD A and PPD B tuberculin and the 
nonspecific immune stimulant PWM). Knowledge of individual variation in 
responses has a clear bearing on ecological immunology and is also informative 
with respect to disease diagnostics in wildlife populations.  
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2.3 Materials and Methods 
Study area and badger sample collection 
Life-history data including diagnostic test results were collected from an 
intensively studied, high-density, population of wild badgers, which is naturally 
infected with M. bovis.  The study population was located within a study area of 
approximately 7 km2 at Woodchester Park, Gloucestershire, UK (Rogers et al., 
1997; Delahay et al., 2000). This badger population has been the subject of a 
capture-mark-recapture study for over 30 years. Data included in the present 
study originated from badgers captured from July 2006, when the IFNᵧ ELISA 
was first introduced, until July 2013.  During this period, consistent testing 
protocols were used with an equal distribution of seasonal trapping events. 
Details from 528 individuals in 27 social groups were recorded during this 
period, with social group structure and social group membership determined by 
capture histories and an annual bait-marking exercise to map territories 
(Delahay et al., 2000).  
Trapping procedures including the handling and sampling of badgers have been 
described elsewhere (Cheeseman et al., 1987; Delahay et al., 2013). Briefly, 
traps were set near active setts/runs associated with each social group, four 
times per year. Trapped animals were anaesthetised before weight (kg), body 
length (cm), and evidence of bite wounds were recorded. Blood samples were 
collected for serology (Chambers et al., 2008) and IFNᵧ ELISA (Dalley et al., 
2008) and clinical samples were taken including faeces, urine, tracheal and 
oesophageal aspirate and bite wound swabs for bacteriological culture of 
M.bovis (Gallagher and Horwill, 1977).   
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Sample Preparation and IFNᵧ testing 
The IFNᵧ test is carried out in two stages, whole-blood stimulation and IFNᵧ 
ELISA (Dalley et al., 2008). The initial step requires the presence of live white 
blood cells and therefore whole blood was processed within 7 hours of sampling 
(Coad et al., 2007; Waters et al., 2007). Heparinised whole-blood was cultured 
in the presence of both PPDA and PPDB antigens at 30 µg/ml, PWM at a 
concentration of 5 µg/ml and a no antigen control (Nil). After 16-24hrs 
incubation at 37oC, the plasma was separated from these four cultures and 
250µl was stored in a 96 well plate. Plasma was then frozen at -80oC prior to 
IFNᵧ ELISA testing. Stimulated plasma was tested in duplicate (100 µl/well) by a 
monoclonal sandwich ELISA (IFNᵧ ELISA) with the end product providing a 
measurement of IFNᵧ produced in the plasma as an optical density (OD) 
measured at 450nm (OD450) (Dalley et al., 2008). Samples were tested in 
duplicate and therefore two OD readings were available for each antigen and 
the nil control.  
Body condition 
In order to determine the body condition of each individual badger the scaled 
mass index (SMI) was calculated following the method by Peig and Green 
(2009), using the following equation:  
?̂?𝑖 = 𝑀𝑖 [
𝐿0
𝐿𝑖
]
𝑏𝑆𝑀𝐴
 
Where Mi is body mass and Li the linear body measurement of individual i, bSMA 
is the scaling exponent estimated by the standardised major axis (SMA) 
33 
 
regression of M on L; L0 is the mean value of the study population; and ?̂?𝑖 is the 
predicted body mass for individual i when the linear body measure is 
standardised to L0. In this study, the scaling coefficients were calculated for all 
badgers using data from 2105 capture events obtained from the Woodchester 
Park database between July 2006 and July 2013. The mass was measured in 
kilograms and body length in cm, bSMA = 3.81 and L0 = 80.35 cm with the final 
calculated SMI measured in kg.   
Group size and exposure 
Badger social group size was calculated by counting the total number of 
individual animals trapped, within each social group, during the 11 months prior 
to each trapping event. The likely exposure of an individual badger to M. bovis 
within its social group was estimated by ascribing a disease status to each 
badger based on diagnostic test results from serology and culture, but not IFNᵧ. 
If an animal was negative by both culture and serology tests and had never 
previously tested positive at any point on either assay, it was deemed negative 
and given a score of zero. If there had ever been a positive serology result then 
the badger was classed as seropositive from the first positive test onwards 
(irrespective of any subsequent negative tests) and given a score of one. If an 
animal tested positive for culture of M. bovis it was deemed an excretor and 
give a score of two from that point onwards (irrespective of any subsequent 
negative cultures). The scores of animals resident in each group were then 
added together (excluding the subject individual) to produce an overall disease 
exposure score for each individual for each capture event.   
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Statistical analyses    
To test the association between duplicate IFNᵧ OD results for each sample, 
Pearson’s product moment correlation was calculated for each of the duplicate 
responses for each of three test outcomes (PPDA, PPDB and PWM). A highly 
significant correlation (p<0.001) was observed for all three and so a mean of the 
duplicates was calculated for use in the data analyses.  
To investigate relationships amongst the three measures of immune response, 
Pearson’s product moment correlations were calculated and a highly significant 
correlation (p<0.001) was observed between all variables. A principal 
component analysis of variation in the responses to PPD A, PPD B and PWM 
was then carried out. This was to create a variable (PC1) that captured the 
correlated elements of variation in the overall magnitude of the three IFNᵧ 
responses and a second, orthogonal component (PC2), which may indicate a 
more specific component to variation in response size. 
To investigate which factors influenced the magnitude of badger immune 
responses based on cytokine IFNᵧ release, after stimulation with PPD A, PPD B 
and PWM, a series of generalised linear mixed models (GLMM) were fitted. 
There were three types of response variable. First, the mean OD450 values 
observed from PPD A, PPD B and PWM were taken as specific responses and 
were log10 transformed to meet normality assumptions (Quinn and Keough, 
2002). Second, the first principal component (PC1) was used to reflect 
between-individual variation in the overall magnitude of IFNᵧ production while 
the second principal component (PC2) was used as a measure of variation in 
the antigen-specific response. Third, due to the likely cross-reactivity of 
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environmental mycobacteria with the PPD B tuberculin, an additional analysis 
was carried out on PPD B OD450 minus PPD A OD450 (B-A). This last response 
(B-A) corresponds to the measure used routinely in bTB diagnostics in badgers 
(Dalley et al., 2008). Fixed effects in all models remained the same for all 
analyses and included individual age (two categories: cubs=≤1 year old and 
adults=>1 year old), sex, season (four categories: spring=March-May, 
summer=June-August, autumn=September-November, winter=December-
February), year of capture (2006-2013), group size (GS), group bTB exposure 
score (bTB exp), wounds present (three categories: Absent, Fresh, Healed) and 
Scaled Mass Index. Potential two-way interactions included in all the models 
were: age*sex, age*season, age*wounds present, age*SMI, age*group size, 
sex*season, sex*wounds present, sex*SMI, sex*group size, season*SMI. Social 
group and individual identity (ID) were fitted as random effects in models to 
account for repeated measures of individuals and variation among social 
groups.  
To improve interpretation and place all input variables on a common scale, 
variables were standardised to a mean of zero and a standard deviation of two 
prior to analyses (Gelman, 2008). Model selection was restricted to a top model 
set based on a cut-off criterion of ΔAICc = 2. The average model coefficients 
were then calculated based on this top model set using the natural average 
method (Burnham and Anderson, 2002). Explanatory variables were deemed to 
have an effect on the magnitude of immune response if the coefficient 
confidence intervals did not span zero (Grueber, 2011). The AICc value and 
Delta value (difference in AICc score from the best candidate model) represents 
the fit of models and the weight value, interpreted as the probability of a given 
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model being the best at explaining the data. All GLMM analyses were carried 
out using package ‘lme4’ in the statistical package R 3.0.1 (cran.r-project.org) 
and models containing different combinations of fixed effects were compared 
using the R 3.0.1 package ‘MuMIn’.   
 
2.4 Results 
A total of 528 individuals (238 males, 290 females) were represented in the 
2105 capture events, of which 1347 were of adults and 758 of cubs. Healed or 
fresh wounds were recorded on 24 % of capture events for adult badgers and 
3.4% for cubs. The mean prevalence of infection (based on results from routine 
diagnostic tests) and group size for the 27 social groups observed in this study 
are summarised in Table 2.1.  
The first two principal components accounted for 76% of the total variation in 
responses to PPD A, PPD B and PWM. PC1 explained 48% of variance and 
showed strong negative correlations with the magnitude of all three antigens 
(PPD A: -0.599; PPD B: -0.522; PWM: -0.607), and so reflected between-
individual variation in the overall magnitude of IFNᵧ production. To ease 
subsequent interpretation, PC1 scores were inverted (0-PC1) so that a greater 
value indicated a larger response.  PC2 explained 28% of variance and showed 
a strong positive correlation (0.851) with PPD B and a negative correlation with 
both PPD A (-0.415) and PWM (-0.322) thus distinguishing variation in IFNᵧ 
production among antigens, likely identifying M. bovis infected individuals and 
an elevated specific immune response.  
37 
 
The top models for each response variable varied slightly in terms of the 
explanatory variables and interactions that were retained (see Table 2.3, 
Appendix I).  GLMMs indicated that variation in responses to PWM, PPD A, 
PPD B, B-A, PC1 and PC2 were significantly associated with various intrinsic 
factors (see Table 2.2). Confidence intervals and relative importance quoted for 
significant results can be found in Table 2.4 (Appendix II). 
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Table 2.1. Mean annual abundance of bTB test positive badgers including 
range (in brackets), and group size for each social group for the study period 
(2006-2013). Abundance is the mean number of animals per year that tested 
positive to any of the three routine diagnostic tests (IFNᵧ, StatPak and culture) 
for the study period (2006-2013). 
Social 
Group 
Abundance 
of test 
positive 
badgers 
Group 
Size 
Social Group Abundance 
of test 
positive 
badgers 
Group 
Size 
Arthurs 4.50  
(0-12) 
10.08 
(0-18) 
Old Oak 3 
(0-8) 
8.55 
(1-13) 
Beech 4.38 
(0-10) 
11.87 
(0-17) 
Park Mill 6.63 
(0-16) 
11.22 
(1-15) 
Breakheart 1.75 
(0-6) 
4.04 
(0-7) 
Peglars 0.88 
(0-4) 
5.19 
(2-7) 
Cedar 5.25 
(1-10) 
8.42 
(2-15) 
Scotland Bank 0.88 
(0-4) 
3.40 
(1-4) 
Cole Park 0.25  
(0-1) 
1.00 
(0-2) 
Septic Tank 6 
(1-9) 
4.10 
(1-7) 
Colliers 
Wood 
1.88 
(0-6) 
3.67 
(0-6) 
Top Sett 4.75 
(0-13) 
6.99 
(3-13) 
Hedge 0.38 
(0-3) 
12.39 
(5-17) 
Trackside 1.75 
(0-5) 
4.71 
(0-7) 
Honeywell 3.63 
(0-12) 
10.05 
(4-16) 
West 3.88 
(0-8) 
8.85 
(5-15) 
Inchbrook 1.75 
(0-4) 
6.77 
(3-10) 
Windsor Edge 8.75 
(3-18) 
8.54 
(3-13) 
Jacks Mirey 5.25 
(2-8) 
6.62 
(1-12) 
Wood Farm 0.38 
(0-2) 
4.88 
(2-8) 
Junction 1 
(0-4) 
9.97 
(2-16) 
Woodrush 2 
(0-4) 
3.38 
(0-6) 
Kennel 2.13 
(0-4) 
7.31 
(0-10) 
Wych Elm 2.38 
(0-7) 
7.60 
(3-11) 
Larch 10.25 
(2-19) 
11.58 
(7-16) 
Yew 3.50 
(1-6) 
11.79 
(4-19) 
Nettle 4.75 
(0-11) 
5.80 
(3-11) 
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Table 2.2. Factors affecting variation in the magnitude of IFNᵧ responses to 
multiple antigens in badgers. Values are the coefficients of standardised 
predictor variables from the averaged set of top models. Significant values, 
where confidence intervals do not overlap 0 are shown in bold. Missing values 
are where that factor did not appear in the top model sets for that response. 
PPD A is the response to stimulation to avian tuberculin, PPD B is bovine 
tuberculin, PWM is pokeweed mitogen, PC1 is the first component of a principal 
component analysis of the first three variables and reflects overall magnitude of 
IFNᵧ responses while PC2 is positively associated with a specific response to 
PPD B relative to PPD A and PWM. B-A is PPD B – PPD A and is the main 
metric used in bovine tuberculosis diagnosis in badgers. The reference levels 
for each factor are: sex = female, age = adults, season = spring, wounds = 
absent. For confidence intervals and relative importance see Table 2.4 
(Appendix II).   
Variables PPD A PPD B PWM PC1 PC2 B-A 
Sex: Male   0.012 -0.012 -0.041 -0.046 -0.083 -0.004 
Age: Cubs -0.036 -0.058  0.113 0.142 -0.153 -0.002 
Season:Summer -0.020  0.008 -0.071 -0.127 0.106  
Season:Autumn -0.018  0.019 -0.122 -0.239 0.146  
Season:Winter  0.066  0.103  0.095  0.467 -0.025  
Year -0.189 -0.198 -0.318 -1.229   0.333 -0.004 
Scaled Mass Index -0.001 -0.035  0.082  0.091   0.016  0.000 
Wounds: Fresh   0.067 -0.076    0.196  0.007 
Wounds: Healed   0.033 -0.037    0.055  0.001 
Group bTB exposure score  0.009  0.124  0.025  0.233   0.239  0.010 
Group size  0.016 -0.028 -0.051 -0.150  -0.002 
Age x Sex -0.029  -0.015    0.147  0.005 
Age x Season:Winter -0.003   -0.205  -0.088  
Age x Season:Autumn  0.050    0.167  -0.096  
Age x Season:Summer -0.016   -0.161   0.088  
Age x Wounds:Fresh   -0.115    
Age x Wounds:Healed    0.078    
Age x Group Size -0.008      
Sex x Season:Winter    0.100    
Sex x Season:Autumn    0.076    
Sex x Season:Summer    0.032    
Sex x Wounds:Fresh   -0.106   -0.007 
Sex x Wounds:Healed    0.008    0.004 
SMI x Age: Cubs   0.054  0.029   0.088   
SMI x Sex: Male  0.034  0.033 -0.061    
Sex x Group Size  -0.040 -0.025 -0.123   
SMI x Season:Winter -0.051 -0.051 -0.196 -0.478   
SMI x Season:Autumn  0.019  0.050 -0.091 -0.028   
SMI x Season:Summer -0.006  0.028 -0.060 -0.099   
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Sex 
There was no significant effect of sex as a main effect on the magnitude of IFNᵧ 
for any of the response variables.  
Age 
When compared to adults, cubs produced significantly lower IFNᵧ responses to 
PPD B and PC2 but higher responses to the more general stimulus of PWM 
(Figure 2.1).  
Season 
All response variables showed significant variation among seasons (Figure 2.2), 
apart from the bTB diagnostic measure B-A where season did not appear in any 
of the thirteen top models. IFNᵧ production was significantly greater in winter for 
PPD A, PPD B, PWM and especially for PC1. Significantly reduced IFNᵧ 
production was noted for PWM and PC1 in autumn and for PWM in summer. 
PC2 showed opposite trends where IFNᵧ production was significantly greater in 
autumn and summer. 
Year 
Year of capture and testing had a significant effect on all the response variables 
analysed. A marked decline from 2006-2013 was apparent for PPD A, PPD B, 
PWM, and PC1. However, a positive trend with time was apparent for PC2 
(Figure 2.3).  
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Body condition  
The effects of body condition (Scaled Mass Index SMI) on IFNᵧ production 
interacted significantly with sex, age and season (Figure 2.4). For PPD A, the 
effect of body condition on IFNᵧ response was significantly greater in male 
badgers than females. For PPD B, the effect of body condition on IFNᵧ 
response was significantly greater in cubs than in adult badgers. The effects of 
body condition also varied among the seasons. For PWM, IFNᵧ levels were 
negatively related to condition in winter but positively related to condition in 
spring.  For PC1, a similar pattern occurs where IFNᵧ production is negatively 
related to condition in winter but positively correlated during spring, summer and 
autumn. After addressing significant interactions, there remained a positive 
effect of condition on IFNᵧ response to PWM (Figure 2.4e). 
Wounds 
Badgers with fresh wounds produced a significantly higher response to PPD B, 
B-A and PC2, compared to those with no recorded wounds. For PWM, the 
opposite effect was apparent, such that IFNᵧ response was significantly lower in 
animals with fresh or healed wounds, compared to those with no recorded 
wounds (Figure 2.5).  The presence of bite wounds was not significantly related 
to the production of IFNᵧ for PPD A or PC1. 
Social group exposure to M. bovis 
IFNᵧ responses to PPD B, B-A, PC1 and PC2 were significantly positively 
correlated with the degree of exposure of the individual badger to M. bovis 
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infected badgers in their social group (Figure 2.6). No significant effects were 
apparent for PPD A or PWM. 
Group Size 
Group size was significantly negatively related to the magnitude of IFNᵧ 
production for PWM and PC1. IFNᵧ responses to PPD A were significantly 
positively correlated with group size (Figure 2.7). 
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Figure 2.1. Box and whisker plots showing the significant age-related differences in IFNᵧ production in response to (a) PPD B, (b) PC2 and (c) PWM. 
Values shown are the top model predicted values; the box shows the median data value (solid black line) and the lower and upper quartiles (25% and 
75% of data). The top and bottom of the whiskers show the range of data excluding any outliers which are represented by the dots. 
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Figure 2.2 Box and Whisker plot to show the seasonal variation in IFNᵧ production for (a) PPD A, (b) PPD B, (c) PWM, (d) PC1 and (e) PC2. The 
values are the top model predicted values; the box shows the median data value (solid black line) and the lower and upper quartiles (25% and 75% of 
data). The top and bottom of the whiskers shows the range of data excluding any outliers which are represented by the dots. 
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Figure 2.3. Box and Whiskers plot of the annual variation from 2006-2013 in the magnitude of IFNᵧ responses of badgers to (a) PPD A, (b) PPD B, (c) 
PWM, The values are the top model predictive values; the box contains the median data values (solid black line) and the lower and upper quartiles 
(25% and 75% of data). The top and bottom of the whiskers shows the range of data excluding any outliers which are represented by the dots.
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Figure 2.3. Box and Whiskers plot of the annual variation from 2006-2013 in the magnitude of IFNᵧ responses of badgers to (d) B-A, (e) PC1 and (f) 
PC2. The values are the top model predictive; the box contains the median data values (solid black line) and the lower and upper quartiles (25% and 
75% of data). The top and bottom of the whiskers shows the range of data excluding any outliers which are represented by the dots.
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Figure 2.4. (a) Scatter plot to show the relationship between the model predicted values of IFNᵧ response to PPD A and the body condition of male 
and female badgers, lines of best fit are included for each sex. (b) Scatter plot to show the relationship between the model predicted values of IFNᵧ 
response to PPD B and the body condition of adult and cubs, lines of best fit are included for both age classes. 
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Figure 2.4. (c) Scatter plots to show seasonal variation and body condition on the model predicted values of IFNᵧ response to PWM. (d) Scatter plots 
to show seasonal variation and body condition on the model predicted values of IFNᵧ responses in the PC1 analyses. 
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Figure 2.4. (e) Scatter plot to show the relationship between body condition and IFNᵧ response levels to PWM, line of best fit included.
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Figure 2.5. Relationships between the presence of bite wounds in badgers and IFNᵧ responses to (a) PPD B (b) PWM (c) PC2 and (d) B-A. The 
values are the top model predicted values; the box contains the median data values (solid black line) and the lower and upper quartiles (25% 
and 75% of data). The top and bottom of the whiskers shows the range of data excluding any outliers, which are represented by the dots. 
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Figure 2.6. Scatter plots to show the effect of bTB exposure (based on a diagnostic test scoring system) on the model predicted values of IFNᵧ 
response for (a) PPD B (b) B-A (c) PC1 and (d) PC2. 
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Figure 2.7. Scatter plots to show the effects of social group size on the model predicted values of IFNᵧ response for (a) PPD A (b) PWM (c) PC1. 
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2.5 Discussion 
By analysing the results of blood tests conducted on a large sample of 
individual badgers, we have revealed both intrinsic and extrinsic sources of 
variation in the cell-mediated immune response. Our measures of immune 
response are specifically assayed by IFNᵧ production in response to lymphocyte 
stimulation with specific mycobacterial antigens (PPD A, PPD B) and with the 
more general antigen pokeweed mitogen (PWM). By using these measures of 
immune response and deriving parameters to indicate variation in the overall 
magnitude of the immune response (PC1) and the more specific components 
(PC2), we have highlighted the between-individual and between-state variation 
in immune response. This variation has a clear bearing on understanding 
variation in the immunological capability of individuals and, in this specific 
instance, on the diagnosis of important infections.  
In this study, sex did not, when considered in isolation, significantly influence 
the magnitude of any elements of the IFNᵧ immune response in badgers. 
However, the age of a badger was correlated with the cell-mediated immune 
response and this relationship varied depending on whether stimulation was 
general or specific. For example, cubs produced more IFNᵧ than adults in 
response to a general stimulus (PWM). Studies in both humans and laboratory 
animals have identified age-related changes in the T-cell component of adaptive 
immunity (Castle, 2000). Gradual lifetime decreases in various cell-mediated 
immune responses such as lymphocyte proliferation to mitogens have been 
observed in humans (Murasko et al., 1987; Wedelin et al., 1982; Hicks et al., 
1983) and dogs (Greeley et al., 2001). Rink et al. (1998) found that IFNᵧ 
54 
 
released by lymphocytes is produced less in the elderly compared to young 
donors and is correlated with a decreased number of CD45RA+/CD8+ T-cells.  
Aging is associated with deterioration of the immune function and is termed as 
immunosenescence (Ginaldi et al., 2001); this deterioration can lead to 
increased susceptibility to infection and disease (Castle, 2000). However, we 
have only distinguished two age classes in the present study and hence a more 
in-depth approach could be used to examine immunosenescence in badgers via 
a decline in PWM IFNᵧ levels at more advanced ages.  
In response to the specific stimulus of PPD B, cubs produced less IFNᵧ than 
adults. The strong effect seen in PC2 further suggests that having taken 
account of the overall magnitude of the IFNᵧ production (PC1), cubs are less 
likely to exhibit a large, specific response, in this case to PPD B. Studies of 
immune performance and ageing have identified a lifetime shift in the 
phenotype of circulating T-cells , with a decrease in naïve T-cells which are 
most probably involved in the general PWM response described above, and 
accumulation of memory T-cells (CD45RO+CD4+ cells) (Thomon and Weigle, 
1989; Nijhuis and Nagelkerken, 1992), which contain normal functioning and 
hypofunctioning memory T-cells in older animals compared to those that remain 
in younger animals (Castle, 2000). This shift might help explain why adults had 
a greater response to the specific antigen (PPD B), as they are more likely to 
have been exposed to M. bovis and therefore developed specific memory T-
cells (Chambers et al., 2009). A lack of significant age-related variation in 
response to PPD A suggests that cubs may be no less likely than adults to have 
been exposed to environmental mycobacteria. The effect of age on B-A 
responses may be associated with the tendency for the IFNᵧ assay for bovine 
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tuberculosis (which is based on B-A) to be less sensitive in cubs than in adults, 
which has resulted in a lower cut-off value being recommended for cubs 
(Chambers et al., 2009).  
The higher prevalence of healed or fresh bite wounds found in adults may also 
have influenced the variation found in the specific and nonspecific immune 
response between adults and cubs. The presence of bite wounds affected the 
cell-mediated immune response differently depending on whether stimulation 
was general or specific. Greater IFNᵧ responses to the specific stimuli (PPD B, 
B-A and PC2) in wounded animals, compared to those without bite wounds 
supports the notion that bite wounding may be an effective route of bTB 
infection for badgers and that this is associated with more rapid progression of 
infection than other routes of infection (Gallagher et al., 1998; Clifton-Hadley et 
al., 1993; Jenkins et al., 2008). Clifton-Hadley et al. (1993) showed that badgers 
with infected bite wounds at first diagnosis appear to have a shorter survival 
rate than those with M. bovis diagnosed from other samples indicating the 
likelihood that these badgers have a more rapidly disseminated form of M. 
bovis. The lower response to PWM observed in wounded animals is difficult to 
explain. Generalized immunosuppression after injury has been noted in studies 
of mice and humans with IFNᵧ activity reported to decrease after accidental 
injury (Abraham and Freitas, 1989; Meldrum et al., 1991) and a reduction of 
lymphocytes and altered T-cell phenotype (Schaffer and Barbul, 1998). Lower 
levels of lymphocyte proliferation in response to mitogenic stimulation have 
been recorded in patients after surgical procedures, accidental trauma, burns 
and haemorrhage (Faist et al., 1993; O’Riordain et al., 1993). Stress hormones 
have also been found to cause adverse effects on lymphocyte function 
56 
 
(Schaffer and Barbul, 1998). Seasonal reproductive activity including territorial 
defence, bite wounding, assertion of sexual dominance, pregnancy and 
lactation (Neal and Cheeseman, 1996) may cause heightened physiological 
stress in an individual (Griffin and Thomson, 1998) perhaps contributing to the 
lower IFNᵧ levels in response to PWM observed in bite wounded animals.   
Significant seasonal variation was observed for both the specific and general 
cell-mediated responses. IFNᵧ levels were highest during the winter months for 
PWM, PPD A, PPD B and the overall immune response of PC1. However PC2 
(representing likely infected individuals) showed higher levels during summer.   
M. bovis can survive and may remain infectious for months in the environment 
(Maddock, 1993; Wilesmith et al., 1986; Courtenay et al., 2006). Badger setts 
provide the ideal conditions for M. bovis to survive due to their complete 
darkness, constant temperature and high humidity (Roper, 1992). During the 
winter months badgers spend more time underground in intimate association 
with one another, and as the duration of aerosol exposure is significantly 
increased in enclosed spaces, with limited air movement (Corner et al., 2011), 
at this time of year setts may provide ideal conditions for 
exposure/transmission. This is consistent with the significantly higher levels of 
IFNᵧ in response to PPD B found during the winter. A study in Ireland by Corner 
et al (2008) found evidence of a higher prevalence of M. bovis infection 
amongst badgers during December (winter) and significantly lower levels in May 
and September (spring/autumn), although no explanation was given. Such a 
seasonal pattern of prevalence would be consistent with the higher levels of 
IFNᵧ in response to PPD B found during the winter months in the present study, 
but would not explain the higher levels of IFNᵧ found in the summer related to 
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PC2. As PC2 represents likely infected individuals based on B-A, a possible 
explanation may be the higher IFNᵧ levels found in response to PPD A. False 
negative results to the IFNᵧ test have occurred in studies of cattle due to high 
levels of IFNᵧ in response to PPD A as well as PPD B (Rhodes et al., 2000; 
Schiller et al., 2010). Other studies in cattle and badgers have also revealed 
that IFNᵧ responses to PPD A may exceed those to PPD B at an early time 
point after M. bovis infection and therefore the time when the diagnostic test is 
performed may play an important role in test accuracy (Rhodes et al., 2000; 
Lesellier et al., 2008; Schiller et al., 2010). These results show a weakness in 
the use of tuberculins for the diagnosis of M. bovis due to the potential cross-
reactivity of PPD A and PPD B and risk of co-infection with M. bovis and other 
mycobacteria (Aagaard et al., 2010). The PC2 results could also reflect 
seasonal variation in badger physiology, particularly that related to reproductive 
behaviour. Female badgers undergo pregnancy during the winter months and 
give birth in late winter/early spring. Mating can start soon after the birth of cubs 
and before weaning which takes place 12 weeks after birth (Roper, 2010; Neal 
and Cheeseman, 1996). Stress caused by reproductive activity (previously 
described), coupled with poor body condition and nutritional stress after the 
winter period of inactivity could have a negative impact on the immune system. 
Studies of food restriction and body mass changes in birds have shown that 
food restriction caused a decrease in the cell-mediated immune response to 
mitogens that were significantly correlated with the percentage of body mass 
lost by each bird (Alonso-Alvarez and Tella, 2001). A reduction in 
immunocompetence may lead to reactivation of latent M. bovis infection into 
progressive disease (Gallagher and Clifton-Hadley, 2000; Gallagher et al, 1998) 
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or heightened susceptibility to establishment of disease following exposure, 
which would be consistent with higher levels of IFNᵧ production in the summer. 
Badgers have the highest body condition scores coming into winter after 
accumulating weight ready for the period of inactivity. Enhanced body condition 
is achieved through increased food uptake during the previous months when 
food is more abundant and this may contribute to a healthier immune system. 
Small mammals and birds have shown elevated immune activity during winter 
(Nelson and Demas, 1996; Nelson, 2004), which may be indicative of the 
presence of greater exposure to infection or an enhancement of disease 
avoidance (Norris and Evans, 2000) during this challenging period. The present 
study revealed a significant positive correlation between body condition and 
IFNᵧ responses to PWM and PC1, thus implying that animals with a higher IFNᵧ 
response to PWM may have a “more active” immune system. However, these 
analyses also show that during the winter months PWM and PC1 levels are 
higher in animals in poorer body condition. Immune responses require fuel in 
the form of nutrients and energy, which can lead to loss of body weight if the 
response is prolonged (Lochmiller and Deerenberg, 2000). The raised PWM 
IFNᵧ levels found during the winter months coupled with the shortage of food 
and reproductive state may cause a loss in body condition in some individuals 
and perhaps explain why a negative correlation was observed. However, this is 
speculative and suggests that further investigation may be required. The body 
condition of badgers does not appear to have a significant effect on the antigen 
specific stimuli (PPD A and PPD B) or within the PC1 and PC2 responses. 
However the interaction between age and body condition of badgers and the 
PPD B response revealed that cubs produced significantly higher levels 
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compared to adults with an increase in body condition. In addition, males 
produced significantly more IFNᵧ to PPD A than females with increasing body 
condition. This is hard to explain but identifies the complex interactions between 
investment and activity in immunity and infection between the sexes. 
The year on year decline in IFNᵧ levels shown in all analyses apart from PC2 
(annual increase possibly due to the annual decline in PWM and PPD A 
accentuating the higher PPD B responses) is also difficult to explain but could 
be attributed to test performance, a physiological or environmental reason or 
some combination of these factors. Investigation into any changes in test 
procedure or reagent batches would be required to see if test performance may 
have changed over time.  
Increased stress may be experienced by individuals living in larger social 
groups if there is a higher level of intra-specific competition for food, territorial 
defence and reproduction. Immune suppression has been associated with 
stress hormones in several species of vertebrate (Nelson et al., 2002), and may 
explain the negative correlation between group size and IFNᵧ levels in response 
to PWM and within the PC1 analyses observed in this study. A study by Beirne 
et al. (2014) has also shown evidence of the trade-off between intra-sexual 
competition and somatic cell maintenance in badgers so this may also be a 
contributing factor. There was no significant association apparent between 
group size and the specific M. bovis response variables (PPD B, B-A and PC2) 
however in the present study badgers living in social groups with a high level of 
exposure to M.bovis showed raised levels of IFNᵧ to the antigen specific 
stimulus. This is to be expected as close associations between badgers of the 
60 
 
same social group including mutual grooming and the use of the same main 
setts may enhance the spread of infection. 
The present study has provided an insight into the effect of various intrinsic 
factors on the cell-mediated immune responses of badgers. Results have 
revealed a wide range of explanatory variables with the potential to significantly 
influence the PWM IFNᵧ response which determines the state of the ‘naïve’ T-
cell population. Those variables that have been shown to significantly influence 
the PPD B IFNᵧ response provide evidence of what intrinsic factors may 
contribute to the likelihood of M. bovis infection/exposure.  
A number of host and environmental factors may influence an individual’s 
immune response and the performance of the diagnostic test, including the 
intrinsic factors observed in this study. Clearly, incorporation of knowledge of 
these intrinsic and extrinsic factors into diagnostic determination of the bTB 
infection status has potential to improve test performance, by controlling for 
variation in test outcomes that does not arise from infection status. There are 
however other factors which may influence the immune response and 
diagnostic test outcomes that were not included in the present study.  Such 
factors include the influence of other infections, disease severity, stress, 
resource availability and their interactions. Further investigation into intrinsic 
factors that specifically influence the M. bovis specific IFNᵧ response would be 
required if they were to be used as a tool to assist in determining the disease 
status of badger individuals/groups in TB eradication programmes. 
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2.8 Appendix I 
Table 2.3. Summary table of top models to explain the influence of various intrinsic factors on each response variable. Inclusion of a given variable is 
indicated by the symbol +, the ΔAICc and Delta value are given to represent the fit of models and the weight to show the probability of the given 
model best explaining the data. 
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PPD A  + + +  + + +  + +      +  + 20 -1626.69 0.00 0.27 
 + + +  + + +  + +      +   17 -1625.38 1.30 0.14 
 + + +  + + + + + +      +  + 21 -1625.34 1.35 0.14 
 + + +  +  +  + +         15 -1625.05 1.64 0.12 
 + + +  + + +  + +   +   +  + 21 -1624.93 1.76 0.11 
 + + +  + +  + + +      +  + 20 -1624.77 1.92 0.11 
 + + +  +  +   +         14 -1624.72 1.97 0.10 
                       
PPD B  + + + + + + +    +      + 18 581.54 0.00 0.17 
  + + + + + + +    +       15 581.81 0.27 0.15 
  + + + + +  +    +      + 17 582.23 0.69 0.12 
  + + + + +  +    +       14 582.53 0.99 0.11 
 + + + + + + + +    +     + + 20 582.92 1.38 0.09 
 + + + + + + + +    +      + 19 583.13 1.59 0.08 
 + + + + + + + +    +    + + + 21 583.19 1.65 0.08 
 + + + + + + + +    +       16 583.30 1.76 0.07 
 + + + + + + + +    +    +  + 20 583.42 1.88 0.07 
 + + + + + + + +    +     +  17 583.49 1.95 0.07 
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PWM + + + + + + +         +  + 18 1250.84 0.00 0.11 
 + + + + + + +        + +  + 20 1251.01 0.25 0.09 
 + + + + + + + +        +  + 19 1251.36 0.52 0.08 
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 + + + + +   + + +         17 5248.88 1.01 0.21 
 + + + + +   +           13 5249.17 1.30 0.18 
  + + + +   +           12 5249.55 1.68 0.15 
 + + + + + +  + +          15 5249.76 1.89 0.13 
                       
B-A +   + +   +           9 -8378.21 0.00 0.14 
 + +  + +   + +          11 -8377.77 0.43 0.11 
 + +  + +   +           10 -8377.49 0.72 0.10 
  
7
7 
 
 +   + +  + +           10 -8377.47 0.73 0.10 
 +   + +   +       +    11 -8377.11 1.10 0.08 
 + +  + +  + + +          12 -8376.90 1.31 0.07 
 + +  +   + + +          11 -8376.61 1.60 0.06 
 +   + +  + +       +    12 -8376.49 1.72 0.06 
 + +  + +   + +      +    13 -8376.44 1.77 0.06 
 + +  + +   +       +    12 -8376.41 1.80 0.06 
    + +   +           8 -8376.35 1.85 0.06 
 +   + + +  +           10 -8376.33 1.88 0.05 
 + +   +   +           8 -8376.20 1.88 0.05 
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2.9 Appendix II 
Table 2.4. Statistical output for all significant results. The top levels for each factor 
variable in the statistical analyses are: sex = female, age = adults, season = spring, 
wounds = absent. All other variables are continuous and therefore no separate 
categories.  
 
 
  
 
 
  
Fixed Effects 2.5%CI 97.5%CI Relative Importance Significance 
PPD A     
(Intercept) -1.159 -1.114   
Season Winter    0.029  0.103 1.00 +++ 
Group Size (GS)    0.000  0.032 0.89 + 
Year  -0.205 -0.174 1.00 +++ 
Sex:SMI    0.005  0.064 0.78 + 
PPD B     
(Intercept) -1.09 -1.03   
Age -0.09 -0.03 1.00 +++ 
Season Winter    0.05  0.16 1.00 +++ 
Wounds Fresh  0.02  0.11 1.00 ++ 
Group Exposure (GE)    0.09  0.16 1.00 +++ 
Year  -0.23 -0.17 1.00 +++ 
Age:SMI  0.00  0.11 1.00 + 
PWM     
(Intercept)  0.04  0.13   
Age  0.08  0.15 1.00 +++ 
Season Winter  0.03  0.16 1.00 ++ 
Season Autumn -0.17 -0.08 1.00 +++ 
Season Summer   -0.11 -0.03 1.00 ++ 
Wounds Fresh -0.13 -0.02 1.00 + 
Group Size (GS)   -0.09 -0.01 1.00 ++ 
SMI  0.01  0.16 1.00 + 
Year -0.35 -0.29 1.00 +++ 
Season Winter:SMI -0.31 -0.08 1.00 +++ 
Season Autumn:SMI -0.18 -0.00 1.00 + 
B-A     
(Intercept)  0.31  0.31   
Wounds Fresh  0.00  0.01 0.95 + 
Group Exposure (GE)  0.01   0.01  1.00 +++ 
Year -0.01  -0.00  1.00 + 
PCA Component 1     
(Intercept)  1.61  1.90   
Season Autumn -0.40 -0.08 1.00 ++ 
Season Winter  0.22  0.71 1.00 +++ 
Group Exposure (GE)  0.12  0.35 1.00 +++ 
Group Size (GS)   -0.26 -0.04 1.00 ++ 
Year -1.33 -1.12 1.00 +++ 
Season Winter:SMI -0.86 -0.10 0.66 + 
PCA Component 2     
(Intercept)  9.42  9.64   
Age - 0.30 -0.01 1.00 + 
Season Autumn  0.03  0.26 1.00 + 
Season Summer    0.00  0.21 1.00 + 
Wounds Fresh  0.06  0.33 1.00 ++ 
Group Exposure (GE)  0.47  0.33 1.00 +++ 
Year  0.24  0.42 1.00 +++ 
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CHAPTER 3  Development of a technique for blood collection from 
unanaesthetised badgers (Meles meles) and application of the Dual-Path 
Platform VetTB diagnostic test in the field. 
 
3.1 Abstract 
Existing methods of Mycobacterium bovis diagnosis in live badgers require the 
collection of blood or clinical samples from captured and anaesthetised animals. 
The development of a simple technique to collect and test blood from 
unanaesthetised badgers in the field would be a valuable tool for disease 
surveillance and management. This study demonstrated proof of concept of a 
method of capillary blood collection which can be used in the field to test for the 
presence of Mycobacterium bovis infection in badgers. Blood collection was 
achieved by using a bespoke restraint cage allowing safe access to the 
badger’s hind leg. A small incision was made in the main pad with a lancet 
device and capillary ooze collected. The blood collection method was 
developed on 57 badgers of which 41 had a valid Dual-Path Platform VetTB 
result in the field and laboratory. We have shown that the accuracy of the DPP 
VetTB test carried out in the controlled conditions of the laboratory cannot be 
replicated when testing under field conditions. Only a moderate agreement was 
observed between tests carried out in the field and the laboratory suggesting 
that stochastic conditions in the field may affect TB diagnostic outcomes. This is 
further supported by receiver operating characteristic curves revealing 
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significantly more accurate results in the laboratory than in the field, when using 
a more sensitive interferon gamma assay as reference.   
 
3.2 Introduction 
Bovine tuberculosis (bTB), caused by Mycobacterium bovis is a serious 
zoonotic disease that has a significant impact on livestock health and 
production (Defra, 2011), which in turn results in substantial costs to the UK tax 
payers and the cattle industry.  The European badger (Meles meles) was first 
recognised as a wildlife host for M. bovis in 1971 during investigation of a bTB 
outbreak on a farm in Gloucestershire (Muirhead et al., 1974). Further research 
identified badgers as a maintenance host and a significant source of M. bovis 
infection in cattle (Krebs et al., 1997).   
From 1973 until 1997, and again since 2011(Defra, 2011) badger culling has 
formed part of bTB control policy in England. In cattle, bTB incidents have 
increased in both number and geographical spread since the 1980s (Krebs et 
al., 1997). Results from the Randomised Badger Culling Trial (RBCT) showed 
that widespread proactive culling reduced cattle TB incidence inside the cull 
zone but increased the incidence in the neighbouring unculled areas.  This was 
believed to be caused by increased movement in badger populations disrupted 
by culling which extended into adjacent areas resulting in increased 
transmission between badgers and from badgers to cattle (Woodroffe et al., 
2006). Badger culling has not discriminated between infected and uninfected 
animals, which may have resulted in a large number of uninfected animals 
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being killed (Buddle et al, 2000) and is therefore a less attractive option from an 
animal welfare standpoint.  In addition, removal of fewer animals might be 
expected to reduce the level of disruption caused by culling and hence the 
negative epidemiological effects (Bielby et al., 2014). 
In 1994 a trial was carried out using a diagnostic test on live badgers to explore 
this approach for targeted culling of infected badgers (Woodroffe et al., 1999). 
Unfortunately identifying and removing infected social groups was severely 
constrained by the low sensitivity of the test and the trial was abandoned.  
Vaccination of wildlife against M. bovis infection is another approach that aims 
to reduce the spread of infection amongst badgers and to other animals (Buddle 
et al., 2000; Chambers et al., 2011; Carter et al., 2012). With the development 
of a suitably sensitive diagnostic test that could be used at trap-side, a test 
vaccinate/remove (TVR) programme might be a more attractive option, allowing 
test positive animals to be removed and test negative animals to be vaccinated.  
Diagnostic tests such as bacterial culture of clinical samples and the interferon 
gamma test (IFNᵧ) are available for the detection of M. bovis in badgers but 
would not be suitable for field application. Both tests require a specialist 
laboratory environment and skilled personnel to carry out the procedure, with a 
minimum test turn-around time of several weeks for culture (Gallagher and 
Horwill, 1977) and 48hrs for the IFNᵧ (Dalley et al., 2008).  The Dual-Path 
Platform VetTB point-of-care test is an immunochromatographic test for rapid 
serological detection of bTB using innovative dual-path platform (DPP) 
technology (Chembio, Medford, NY, USA). The VetTB test has two 
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nitrocellulose strips that are connected in a T-shape inside the cassette device, 
this allows independent delivery of sample and antibody detecting reagent 
(protein A/G hybrid conjugated to colloidal gold particles) (Boadella et al., 2011). 
Another advantage of the VetTB test is that it detects two target diagnostic 
antigens of M. bovis (MPB83, ESAT6/CFP10) on two separate lines. Line one 
contains antigen MPB83 and line two ESAT6/CFP10 (Chambers, 2013). In the 
presence of antibodies specific to these antigens, a line is produced the 
intensity of which can be measured in reflectance light units (RLU). The RLU 
values correspond to the amount of antibodies present in the sample and a cut-
off value can be applied to determine a positive/negative result. In addition, 
results can be read by eye. 
This test could be used at trap-side because a result can be achieved within 20 
minutes, and its application has been described in other wildlife species 
(Greenwald et al., 2009, Buddle et al., 2010 and Boadella et al., 2011). This 
would enable captured badgers to be kept in cage traps for a relatively short 
period of time, during which a serological test could be carried out. However, in 
order to conduct the test in the field, it is necessary that a robust protocol be 
developed for the collection of a viable blood sample from the unanaesthetised 
badger. 
Another consideration when developing this protocol concerns test performance 
in the field. The manufacturer’s instructions state that the test needs to be 
carried out on a flat surface at temperatures of 18 to 300C with good lighting in 
order to interpret the results more accurately. Considering the test has been 
developed to perform optimally under these controlled conditions, replicating 
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them in the field may affect test accuracy due to environmental factors such as 
temperature, uneven terrain and low light levels. In addition, contamination of 
the sample may occur due to the nature of blood collection in the field. Blood 
taken from an unanaesthetised badger will not be as aseptic to that taken from 
an animal under anaesthetic in a controlled environment.   
The present study describes the development of a method for capillary blood 
collection on 57 live and unanaesthetised badgers and its application on the 
VetTB test in the field. The study then compares VetTB test results from 41 
capillary blood samples successfully taken and tested in the field from 
unanaesthetised badgers with those from venous whole blood samples taken 
from the same animals on the same occasion but under controlled conditions, 
i.e. under anaesthetic and the tests run in a laboratory.   
  
3.3 Method 
Overview 
Badgers were trapped as part of the long-term project at Woodchester Park, 
Gloucestershire, UK (see Delahay et al., 2000; Vicente et al. 2007).  At each of 
ten scheduled trapping events from May 2014 to January 2015, trap-side 
collection of blood was attempted from a selection of trapped but 
unanaesthetised badgers. If blood collection was successful then the sample 
was tested for the presence of antibodies against M. bovis antigens MPB83, 
ESAT6 and CFP10 using the VetTB test (Chembio Diagnostic Systems Inc. 
USA).  
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The use of a novel badger restraint cage (Figure 3.1 & 3.2) developed by the 
Animal and Plant Health Agency (APHA) (previously Food and Environment 
Research Agency) in partnership with Envisage PMS Ltd, allowed the operator 
to gain access to the hind leg of an unanaesthetised badger without risk of 
injury to either operator or restrained badger. Each trapped badger was 
transferred from the trap into the restraint cage. A hind leg was then gently 
taken out of the cage through a window in the cage and the main pad of the foot 
was cleaned with water soaked cotton wool and dried using a paper towel. A 
small incision was then made by applying the lancet of choice to the skin of the 
main pad (Figure 3.3). If capillary ooze was produced from this incision, 10 µl 
(or as close to this volume as possible) was collected in a heparinised capillary 
tube (Figure 3.4) and placed directly onto the VetTB test well (Figure 3.5). The 
badger was then taken back to a dedicated sampling facility as part of the 
routine trapping project to undergo further sampling under anaesthesia 
(Delahay et al., 2013). At the sampling facility, whole blood was collected in a 4 
ml BD heparin vacutainer tube and tested using the identical VetTB test in the 
adjoining laboratory.    
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Figure 3.1. Novel badger restraint cage. Figure 3.2. Novel badger restraint cage in 
use. 
   
Figure 3.3. Hind leg access 
and lancet use.        
Figure 3.4. Capillary ooze  
collection from incision site.        
Figure 3.5. Blood 
application to VetTB test 
sample well. 
 
Lancet for Skin Puncture 
To create sufficient capillary ooze from which to take a sample, an effective 
method of making an incision in the central depression of the main pad of the 
badger’s hind foot (site determined by trials carried out by APHA on both wild 
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and captive badgers) was required. Four different lancets were considered.  
These included a MiniCollect® safety lancet, penetration depth 2 mm with blade 
with and without safety casing (Greiner Bio-One, product code 450429, Figure 
3.6a and 3.6b), and a 2 mm needle lancet (Sterimatic Worldwide Ltd, Figure 
3.6c). Both of these lancets are used for blood sampling in humans. The two 
other lancets sourced are used to draw blood from the saphenous vessel of 
mice and rats; these consisted of a 4 mm and 6 mm goldenrod animal lancet 
with a stainless steel triangular blade (World Precision Instruments, Inc., 
product code 504540 and 504553. Figure 3.6d & e). For the human lancets it 
was decided that the 2 mm blade in the safety casing would not create enough 
depth to penetrate the skin of the badger’s pad so the blade was removed from 
the safety casing.     
 
Figure 3.6. Various lancet devices trialled; (a) 2 mm blade with safety casing, (b) 2 mm 
blade with safety casing removed, (c) 2 mm needle lancet, (d) 4 mm goldenrod animal 
lancet, and (e) 6 mm goldenrod animal lancet. 
 
(a) (b) (c) (d) (e) 
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Blood Collection Apparatus  
A sample of 10 µl of whole blood was required to carry out the VetTB test as per 
manufacturer’s instructions (Chembio Diagnostic Systems Inc, 2012). Various 
collection vessels were sourced including plastic pastettes, capillary tubes and 
a vacuum device. Four types of plastic pastette were trialled with drop volume 
ranging from 20 µl to 25 µl. Due to the larger drop volume of these pastettes 
any blood collected is dispensed into a heparin microtainer blood collection tube 
(BD, product code 365965).  Pastettes included a paddle pastette (131 mm 
length, 25 µl/drop; Alpha Laboratories, product code LW4292. Figure 3.7a), an 
extended fine tip mini pastette (104 mm length, 20 µl/drop; Alpha Laboratories, 
product code LW4237. Figure 3.7b), a fine tip ultra-micro pastette (51 mm 
length, 22 µl/drop; Alpha Laboratories, product code LW4243. Figure 3.7c) and 
a small bulb fine tip pastette (36 mm length, 25 µl/drop; Alpha Laboratories, 
product code LW4697. Figure 3.7d).  
Capillary tubes of different volumes were sourced alongside various expulsion 
devices. To minimise the risk of whole blood clotting immediately after 
collection, four types of heparinised capillary tubes where sourced, two of which 
were glass: calibrated micropipette (127  mm length, 44.7 µl capacity; 
Drummond Scientific Company, product code 2-000-044-H. Figure 3.8a) and 
Microhaematocrit tube (40 mm length, 5 µl capacity; International Scientific 
Supplies, product code GC0060. Figure 3.8c). Two types of plastic capillary 
tubes were trialled: plasticrit plastic haematocrit tube (75 mm length, 70.27 µl 
capacity; Drummond Scientific Company, product code 8-000-7520-H. Figure 
3.8b) and a preassembled capillary with a heparinised click clack closure 
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microtube (250 µl capacity; Sanguis Counting Gmbh, product code 682503. 
Figure 3.8d). Excluding the last preassembled tube the capillaries required a 
secondary method to expel the contents directly onto the test sample pad. Two 
types of equipment were sourced for this purpose, the first was an aspirator 
tube assembly (Alpha Laboratories, product code 2-000-000) where the tubing 
was cut short and attached to a 5 ml syringe (Figure 3.9a) and a 1 ml syringe 
(Figure 3.9b). The second was a simple microcap bulb dispenser (Alpha 
Laboratories, product code 1-000-9000. Figure 3.9c). Both systems rely on 
capillary action to draw up the blood, which is then dispensed by air 
displacement caused either by pushing down on the syringe (air drawn into 
before blood collection) or manually squeezing the bulb. Figure 3.10a, b & c 
shows each device with a different capillary tube attached.    
The final blood collection device that was trialled was the Innovac ® Quick-Draw 
® Capillary Whole Blood Collection System which consists of the Innovac 
Vacuum Handle (Innovative Med Tech, product code 15-500. Figure 3.11a), a 
disk filter (Innovative Med Tech, product code 15-501. Figure 3.11b), a heparin 
quick draw adapter (Innovative Med Tech, product code 15-980. Figure 3.11c) 
and a microtainer with microguard (BD, product code 365965. Figure 3.11d). 
The apparatus was assembled as shown in Figure 3.12. Once assembled, the 
battery powered vacuum handle aspirates blood droplets present on the 
puncture site into the container.  
To make a blood drop form more easily and prevent smearing or dribbling of 
blood, petroleum jelly (Vaseline) was spread over the site prior to making the 
incision as described for human blood collection (McDermott, et al. 2010). 
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Figure 3.7. Pastettes. (a) Paddle pastette. 
(b) Extended fine tip mini pastette. (c) Fine 
tip ultra-micro pastette. (d) Small bulb fine 
tip pastette.  
Figure 3.8. Heparin coated capillaries. (a) 
44.7 µl capacity, glass. (b) 70.27 µl 
capacity, plastic. (c) 5 µl capacity, glass. 
(d) 250 µl capacity with heparinised 
microtube.   
  Figure 3.9. Expulsion devices. (a) Aspirator 
tube assembly with 5 ml syringe. (b) 
Aspirator tube assembly with 1 ml syringe. 
(c) Microcap bulb dispenser.   
Figure 3.10. Expulsion devices with 
capillaries. (a) 5 ml syringe & 5 µl capillary 
(b) 1 ml syringe & 70.27 µl capillary. (c) 
Microcap bulb & 44.7 µl capillary.     
(a) (b) (c) (d) (a) (b) (c) (d) 
(a) (b) (c) (a) (b) (c) 
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Figure 3.11. Innovac® Quick Draw® Capillary 
whole blood collection device. (a) Vacuum 
handle. (b) Disk filter. (c) Heparin quick draw 
adapter. (d) Microtainer.           
Figure 3.12. Assembled Innovac ® 
Quick Draw ® Capllary whole Blood 
collection device. 
 
 
Dual Path Platform Method 
The VetTB test was carried out as per manufacturer’s instructions (Chembio 
Diagnostic Systems Inc, 2012). In brief, collected blood was added to the round 
sample and buffer well one (Figure 3.13a) of the VetTB cassette followed by 
two drops of diluent buffer. A timer was set for five minutes, after which four 
drops of diluent buffer was added to the square buffer well two (Figure 3.13b). 
The timer was set for a further 15 minutes. After a total of 20 minutes the results 
were read both qualitatively (positive/negative) and quantitatively (VetTB 
Reader) in both the field and the laboratory. A red/pink coloured line should 
always be present in the control area (Figure 3.13d) if the test has been 
a b 
(a) 
(b) 
(c) 
(d) 
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performed correctly. In the absence of a control line after 20 minutes the test 
was considered to have failed. A positive test result was interpreted qualitatively 
as the presence of a red/pink line on either of the test lines one and two in the 
result window (Figure 3.13c and 3.15) and negative if there were no lines 
present (Figure 3.16). Results were also measured quantitatively by using the 
Chembio VetTB Reader (Figure 3.14), which measures the strength of each line 
in RLU. No negative/positive result was given by the VetTB readout as a 
generally applicable positive cut-off value for this test is yet to be determined.   
  
Figure 3.13. VetTB cassette used for 
the detection of antibodies to M. bovis 
antigen MPB83 (test line one) and 
ESAT6/CFP10 (test line two). (a) 10 µl 
sample and two drops diluent well. (b) 
four drops diluent well two. (c) Test line 
one and two. (d) Control line. 
        
Figure 3.14. Portable Chembio VetTB reader 
showing the RLU of a sample tested in the 
field.    
(a) 
(b) (c) (d) 
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Figure 3.15. Positive VetTB result in line 
one with control line present. Negative 
VetTB result in line two. 
Positive/negative results assigned 
qualitatively.                         
Figure 3.16. Negative VetTB result with 
control line present. Negative result 
assigned qualitatively. 
 
Statistical Analyses  
Statistical analyses were carried out to compare the VetTB test results from 
samples taken in the field at trap-side with those from samples taken under 
controlled conditions in the sampling facility and tested in the laboratory. 
Analyses were used to determine if there was sufficient agreement between the 
test procedures being carried out under different conditions. Cohen’s Kappa 
statistic was used to test for agreement between dichotomous outcomes 
(positive and negative) and interpreted using the nomenclature described by 
Landis and Koch (1977). The association between quantitative results (RLU) 
was determined by Lin’s Concordance Correlation Coefficient (CCC) as 
described by Lin (1989 and 2000) to test for agreement between the continuous 
measures obtained by the two methods. Qualitative and quantitative analyses 
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were carried out for each of the test lines (MPB83 and ESAT6/CFP10) both 
separately and in combination.    
In addition Receiver Operator Characteristic (ROC) curves were plotted to 
investigate the relationship between the VetTB test results in both the laboratory 
and the field. A test is said to be 100% accurate against the standard it is being 
measured against if the ROC curve passes through the point (0,1) on the unit 
grid resulting in an AUC area of 1.0. The closer a ROC curve comes to this 
point the better its discriminating ability. A test that cannot discriminate between 
negative and positive corresponds to a ROC curve that follows the diagonal of 
the grid with an AUC area of 0.5 (DeLong et al, 1988). To measure the 
accuracy of the test, the area under the ROC curve (AUC) was calculated for 
each test condition and compared statistically using the methods described by 
DeLong et al. (1988). In the absence of a ‘gold standard’ and as the true 
infection status of each badger was unknown, the ROC curves produced for the 
VetTB test were based on the results of other imperfect routine diagnostic tests 
conducted on this population of badgers (Tomlinson et al., 2014). Routine tests 
included culture of clinical samples (Gallagher and Horwill, 1997), StatPak test 
(Chambers et al., 2008) and the IFNᵧ (Dalley et al., 2008). A study by Drewe et 
al. (2010) provided sensitivity and specificity estimates for each of these routine 
diagnostic tests. Culture had a low sensitivity of 8% but was highly specific at 
99.8%. StatPak showed a sensitivity of 50.4% and a specificity of 96.9% and 
the IFNᵧ showed a higher sensitivity of 79.9% with a specificity of 95%. ROC 
curves were plotted against each diagnostic test individually and in combination 
based on the individual badger’s test history derived from the long-term study. 
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This included test data from previous capture events. Hence, if at any time point 
prior to the capture event, a positive test result was found in any of the three 
routine tests, then the badger was deemed positive for that test thereafter 
regardless of any further negative test results. An ROC curve was also plotted 
using the imperfect routine diagnostic tests in combination, where an overall 
positive outcome was determined if any of the three test results were positive. 
   
3.4 Results 
Overview 
There were ten capture events involving 57 badgers during the study period. A 
valid VetTB test result was obtained in both the field and laboratory from 41 
(72%) of these animals. The VetTB test was unavailable during the first 
scheduled sampling event so no tests were carried out on four badgers where 
blood was collected successfully. There were four unidentified individuals with 
results in the field only as they were not taken back to the sampling facility for 
subsequent sampling and identification. Blood collection was unsuccessful for 
eight badgers and therefore no VetTB test was carried out; of these eight, four 
had been released prior to any attempt to collect a sample. This included two 
adult animals that were released due to excessive rotation in the restraint cage, 
one small cub, which could not restrained due to its size and another adult that 
was extremely agitated. For the remaining four badgers, sample collection was 
unsuccessful due to insufficient blood flow. 
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Where blood was successfully collected, volume varied from the target of 10 µl 
to <5 µl (Table 3.1), with a mean of 7.4 µl. The full 10 µl of blood was collected 
from 22 of the 41 badgers that were restrained and provided VetTB test results 
for blood collected both at trap-side sampling and in the sampling facility.  A 
useable blood sample was collected from a further 19 out of 41 animals 
although the quantity was less than the manufacturer’s recommendation of 10 
µl. As the methods were refined, sampling success increased and the target 
volume of 10 µl was achieved more frequently.  All samples collected in the 
sampling facility were 10 µl in volume.  
 
Table 3.1. Quantity of blood collected from unanaesthetised badgers at trap-side.                                                                             
No. badgers Blood Quantity (µl) 
22 10 
3 5-10 
9 5 
7 <5 
41 Mean = 7.4 (SD = 3) 
 
After trialling all the products described, the best performing combination for 
capillary blood collection was the 4 mm goldenrod animal lancet with the 40 mm 
length, 5 µl capacity heparinised microhaematocrit tube and microcap bulb 
dispenser (Figure 3.17). As a result of the capillary size, for a sample volume of 
10 µl it was necessary to use two tubes.    
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Lancet for skin puncture 
Out of the two human lancets trialled, the 2 mm blade removed from the safety 
casing produced a better incision compared to the 2 mm needle lancet, as the 
shape of the blade allowed the operator to make a slightly larger incision. 
However, blood flow was still insufficient and therefore the 4 mm lancet was 
trialled. The 6 mm goldenrod animal lancet was not trialled as the 4mm lancet 
was adequate at producing a large enough incision to significantly improve 
capillary ooze and repeatedly obtain the target volume of 10 µl.  
Blood Collection Apparatus  
Following successful incision, blood tended to spread outwards from the 
incision site without forming a droplet. This created certain difficulties when 
using some of the products described. The use of Vaseline to aid in droplet 
formation was unsuccessful as it appeared to clog the blood collection device. A 
thinner application of Vaseline may have prevented this from happening but this 
was not tested.  Blood collection using the plastic pastettes was the least 
successful approach as in the event of a small amount of blood being collected 
the uptake of air with the sample resulted in the blood being sucked further up 
the tube and in some cases into the bulb, preventing expulsion onto the sample 
well of the VetTB test.  The use of capillaries was more successful but 
depended on the diameter and length of the capillary. Both the plastic capillary 
and the preassembled tube were unsuccessful due to their larger diameter 
resulting in a poor capillary uptake. The diameter of both the 5 µl and 44.7 µl 
glass capillaries was the same but the larger capillary was not used in the field 
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as it was prone to breakages during assembly. The 5 µl capillary was the most 
effective at collecting a blood sample and did not break. Once collected in the 
capillary, the sample was expelled either using the syringe or the bulb method. 
Use of the syringe tended to cause the sample to spray out of the capillary 
whereas no spray was observed using the microcap bulb dispenser. 
The Innovac Quick-Draw was tested on anaesthetised animals only. Collection 
of blood was unsuccessful due to spreading from the incision site with no 
droplet formation.  
 
Figure 3.17. Blood collection devices of choice to successfully collect a 5 µl blood 
sample (two samples collected for VetTB test).  
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Other Observations 
The time taken to deliver the blood from the capillary tube onto the VetTB test 
was important; after 2 minutes of collection the sample appeared to clot in the 
heparinised capillaries which hampered expulsion onto the sample well. This 
was only an issue when there was difficulty getting a second tube filled to 
achieve the 10 µl quantity required.  
Blood flow varied between badgers with some producing better capillary ooze 
than others. In some instances delayed capillary ooze occurred and in other 
instances insufficient capillary ooze was present to take a sample.    
Statistical Analyses of VetTB Test data 
Qualitative Interpretation 
Test Band One (MPB83) 
Results showed that ten animals tested positive at trap-side compared to 14 in 
the laboratory where the standard protocol was used. The Cohen’s Kappa index 
for these samples is 0.42 (Table 3.2), which indicates only moderate agreement 
between methods. When samples with volume  <10 µl were removed, seven of 
the 22 remaining samples were positive at trap-side and eleven were positive in 
the laboratory, giving a Cohen’s Kappa index of 0.46 which was still in the 
moderate agreement category (Table 3.3).  
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Table 3.2. The frequency of positive and negative results for the first test band of the 
VetTB test (MPB83) for all samples tested at trap-side vs laboratory (including the 
Cohen’s Kappa index value). 
 Laboratory Total 
Trap-Side Positive Negative  
Positive 7 3 10 
Negative 7 24 31 
Total 14 27 41 
Kappa index 0.42 
  
Table 3.3. The frequency of positive and negative results for the first test band of the 
VetTB test (MPB83) excluding samples of <10 µl, tested at trap-side vs laboratory 
(including the Cohen’s Kappa index value). 
 Laboratory Total 
Trap-Side Positive Negative  
Positive 6 1 7 
Negative 5 10 15 
Total 11 11 22 
Kappa index 0.46 
 
Test Band Two (ESAT6/CFP10) 
Results showed that seven animals tested positive on the second test line of the 
VetTB test both at trap-side and in the laboratory. The Cohens Kappa index for 
these samples is 0.53, falling to 0.50 when samples of <10 µl were removed. In 
both cases there is still only moderate agreement between field and laboratory 
tests (Table 3.4 and 3.5).  
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Table 3.4. The frequency of positive and negative results for test band two of the VetTB 
test (ESAT6/CFP10) for samples tested at trap-side vs laboratory (including the 
Cohen’s Kappa index value). 
 Laboratory Total 
Trap-side Positive Negative  
Positive 5 3 8 
Negative 3 30 33 
Total 8 33 41 
Kappa index 0.53 
  
Table 3.5. The frequency of positive and negative results for test band two of the VetTB 
test (ESAT6/CFP10) excluding samples of <10 µl, tested at trap-side vs laboratory 
(including the Cohen’s Kappa index value). 
 Laboratory Total 
Trap-side Positive Negative  
Positive 5 2 7 
Negative 3 12 15 
Total 8 14 22 
Kappa index 0.50 
 
Test Bands Combined 
When combining the results of the VetTB test for test lines one and two, 16 
animals tested at trap-side had a positive result with 17 also testing positive in 
the laboratory. A Cohen’s Kappa index value of 0.44 was calculated for all 
samples and was unchanged when samples of <10 µl were removed, indicating 
moderate agreement (Table 3.6 and 3.7). 
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Table 3.6. The frequency of positive and negative results for the VetTB test when both 
test bands were combined for samples tested at trap-side vs laboratory (including the 
Cohen’s Kappa index value). 
 Laboratory Total 
Trap-side Positive Negative  
Positive 11 5 16 
Negative 6 19 25 
Total 17 24 41 
Kappa index 0.44 
  
Table 3.7. The frequency of positive and negative results for the VetTB test when both 
test bands were combined but excluding samples of <10 µl, tested at trap-side vs 
laboratory (including the Cohen’s Kappa index value). 
 Laboratory Total 
Trap-side Positive Negative  
Positive 10 2 12 
Negative 4 6 10 
Total 14 8 22 
Kappa index 0.44 
 
Quantitative Interpretation 
VetTB Line One (MPB83) 
Relative light units ranged from 22.34-6425 (median 60.87) for trap-side tests 
and 7.41-6611 (median 67.54) for laboratory tests. When results from the two 
approaches were compared, Lin’s concordance correlation coefficient (CCC) 
varied depending on the quantity of blood in the field sample. Samples of 10 µl 
showed the best agreement with a CCC of 0.79 reducing to 0.24 for field 
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samples of <10µl. All samples combined resulted in a CCC value of 0.78 (Table 
3.8 and Figure 3.18).  
VetTB Line Two ESAT6/CFP10 
RLU ranged from 0.00-226.2 (median 0.00) for trap-side tests and 0.00-308.5 
(median 1.87) for laboratory tests. When results from the two approaches were 
compared, Lin’s concordance correlation coefficient varied depending on the 
quantity of blood sample used. Samples of 10 µl showed the best agreement 
with a CCC of 0.51 reducing to -0.10 for samples of <10µl. All samples 
combined resulted in a CCC value of 0.43 (Table 3.8 and Figure 3.18).  
Table 3.8. Lin’s concordance correlation coefficient (CCC) values showing 95% 
confidence intervals for VetTB test lines one and two.  
Line 1 MPB83 CCC 95% CI 
All Samples 0.78 0.65-0.87 
10 µl volume 0.79 0.58-0.90 
<10 µl volume 0.24 0.15-0.33 
Line 2 ESAT6/CFP10   
All Samples 0.43 0.17 - 0.64 
10 µl volume 0.51 0.14 - 0.76 
<10 µl volume -0.10 -0.38 - -0.20 
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Figure 3.18. Scatter plots showing concordance of RLU between samples tested at trap-side and in the laboratory a) VetTB test line one (MPB83) b) 
VetTB test line two (ESAT6/CFP10).  
(a) 
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ROC Analyses 
ROC analyses for VetTB test line two shows mostly low AUC values relative to 
the reference tests, apart from those tested at trap-side against culture results 
(Table 3.9). ROC analyses for VetTB test line one showed that tests carried out 
in the laboratory were more accurate against the reference tests StatPak, IFNᵧ 
and tests combined compared to those carried out at trap-side. When culture 
was used as the reference test, the opposite was observed where VetTB results 
from field tests were more accurate than those tested in the laboratory (Table 
3.9).  
Culture ROC Analyses 
ROC analyses carried out for culture results were based on 34 negative cases 
and seven positive cases. An AUC value was calculated separately for samples 
tested at trap-side and in the laboratory for both test lines. No significant 
difference was found between curves for either test line (Table 3.9. Figure 
3.19).  
StatPak ROC Analyses 
ROC analyses carried out for StatPak results were based on 21 negative cases 
and 20 positive cases. An AUC value was calculated separately for samples 
tested at trap-side and in the laboratory for both test lines. No significant 
difference was found between curves for either test line (Table 3.9. Figure 
3.20).  
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IFNᵧ ROC Analyses 
ROC analyses carried out for IFNᵧ results were based on 26 negative cases 
and 15 positive cases. An AUC value was calculated separately for samples 
tested at trap-side and in the laboratory for both test lines. A significant 
difference was found between AUC values for trap-side and laboratory tests for 
VetTB test line one (p<0.04) and test line two (p<0.018) with the laboratory tests 
showing better agreement than field tests (Table 3.9. Figure 3.21). 
Combined Tests ROC Analyses 
ROC analyses carried out for the combined test results were based on 18 
negative cases and 23 positive cases. An AUC value was calculated separately 
for samples tested at trap-side and in the laboratory for both test lines. No 
significant difference was found between curves for either test line (Table 3.9. 
Figure 3.22).  
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Table 3.9. Statistical analyses of AUC values generated from samples tested by VetTB 
test at trap-side and in the laboratory, against three imperfect diagnostic tests, 
individually and in combination. Values shown in bold represent a significant difference 
between AUC values between the two test conditions.  
Line 1 MPB83 Culture DS Stat Pak DS IFNᵧ DS Tests 
Combined 
Trap-side AUC 
95% CI 
0.76 
0.53-0.99 
0.74 
0.59-0.89 
0.83 
0.70-0.96 
0.75 
0.60-0.90 
Laboratory AUC 
95% CI 
0.70 
0.40-1 
0.85 
0.73-0.98 
0.96 
0.91-1 
0.87 
0.76-0.98 
Z-Value 0.74 1.50 2.05 1.55 
P-Value 0.46 0.13 0.04 0.12 
Line 2 
ESAT6/CFP10 
    
Trap-side AUC 
95% CI 
0.73 
0.61-0.85 
0.51 
0.34-0.68 
0.65 
0.49-0.81 
0.5 
0.32-0.67 
Laboratory AUC 
95% CI 
0.55 
0.34-0.75 
0.59 
0.41-0.76 
0.45 
0.26-0.64 
0.61 
0.44-0.78 
Z-Value 1.49 -0.53 -2.37 -0.78 
P-Value 0.13 0.59 0.018 0.44 
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Figure 3.19. ROC curve analyses for VetTB test performance in relation to the culture disease status of badgers from samples tested at both trap-
side and in the laboratory including AUC values with 95% CI. Each point on the curve represents a different RLU value for the test and is plotted 
against the sensitivity and specificity corresponding to that RLU value, based on the culture disease status of 41 badgers used for testing. (a) Test 
line one (MPB83) and (b) test line two (ESAT6/CFP10).
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Figure 3.20. ROC curve analyses for VetTB test performance in relation to the StatPak disease status of badgers from samples tested at both trap-
side and in the laboratory including AUC values with 95% CI. Each point on the curve represents a different RLU value for the test and is plotted 
against the sensitivity and specificity corresponding to that RLU value, based on the StatPak disease status of 41 badgers used for testing (a) test 
line one (MPB83) and (b) test line two (ESAT6/CFP10).
  
 
1
09
 
 
 
Figure 3.21. ROC curve analyses for VetTB test performance in relation to the IFNᵧ disease status of badgers from samples tested at both trap-side 
and in the laboratory including AUC values with 95% CI. Each point on the curve represents a different RLU value for the test and is plotted against 
the sensitivity and specificity corresponding to that RLU value, based on the IFNᵧ disease status of 41 badgers used for testing (a) test line one 
(MPB83) and (b) test line two (ESAT6/CFP10).
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Figure 3.22. ROC curve analyses for VetTB test performance in relation to combined diagnostic test disease status of badgers from samples tested at 
both trap-side and in the laboratory including AUC values with 95% CI. Each point on the curve represents a different RLU value for the test and is 
plotted against the sensitivity and specificity corresponding to that RLU value, based on the combined diagnostic test disease status of 41 badgers 
used for testing (a) test line one (MPB83) and (b) test line two (ESAT6/CFP10).
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3.5 Discussion 
The aim of this study was to develop a method of collecting a viable capillary 
blood sample from an unanaesthetised badger in the field and to evaluate its 
use to diagnose bTB infection using a rapid trap-side test for use in the field. 
Development of a repeatable and cheap method to achieve this may aid the 
implementation of future policy for TB control programmes such as a test and 
vaccinate/remove option.   
With use of a novel restraint cage which allowed safe access to the badger’s 
hind leg the development of a method to collect a target blood volume of 10 µl 
from unanaesthetised badgers at trap-side was achieved during the course of 
this study. Continuous refinement of the method meant the target blood volume 
was reached with increasing reliability. A higher success rate was particularly 
apparent when using the 4 mm goldenrod animal lancet, 5 µl microhaematocrit 
tubes and microcap bulb (Figure 3.17).  
In the four cases where blood collection was not attempted, cage design 
appeared to be the limiting factor. Excessive rotation by the badger prevented 
the operator from gaining access to a hind leg in two adults. The cage was not 
appropriate for restraining small cubs. Further cage improvements may be 
required to reduce the likelihood of this re-occurring. A separate smaller cage 
design for use with cubs could be explored. 
When blood collection was attempted there were several obstacles apparent.  
On four occasions insufficient blood flow to the incision site prevented collection 
of a suitable sample. It was noted that this occurred on mornings that were 
particularly cold, although air temperature was not routinely recorded as part of 
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the study. Literature regarding blood collection in humans describes rubbing the 
area prior to incision and use of heat pads to increase the rate of blood flow to 
the target site and allow more blood to be collected before bleeding ceases.  
(Ellison et al., 2002 and Edelbroek et al., 2009). Use of heat pads could be an 
option to encourage blood flow to the area especially if sampling in colder 
weather, although the badger’s welfare would need to be taken into 
consideration as this could mean a longer restraint time potentially causing 
additional stress to the badger.  
Another observation was the difficulty of getting blood from badgers that 
appeared dehydrated or in bad condition possibly due to disease.  Two of the 
four badgers where no blood sample was achieved had a positive M. bovis 
culture result. Anecdotal evidence of badgers sampled under anaesthesia 
suggests increased difficulty in collecting blood when the animal is in very 
advance stages of disease, although this has not previously been reported in 
the literature.  
The limited volume of the microhaematocrit tube meant that to achieve a target 
blood quantity of 10 µl two separate tubes were required. This was not ideal as 
the blood had a tendency to clot in the heparinised tube if the second sample 
was not achieved in good time. Clotting of blood samples hindered expulsion 
onto the test area and reduced the quantity of blood available.   
Current diagnosis of M. bovis infection in live badgers relies on samples 
collected under anaesthesia which is labour-intensive, time-consuming and 
expensive.  In addition, most of the diagnostic tests currently available take too 
long to provide trap-side results and require specialist laboratory facilities and 
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equipment. Both culture of clinical samples and the IFNᵧ test also rely on 
sample types and quantities that would be difficult if not impossible to collect 
from an unanaesthetised badger. Serological tests such as the VetTB test that 
detects antibodies to M. bovis antigens such as MPB83 and ESAT6/CFP10 are 
a better option. This test requires only a 10 µl sample, can be performed 
anywhere and produces a result in no more than 20 minutes. Successfully 
collecting blood from 41 unanaesthetised badgers meant that the VetTB test 
could be performed directly in the field and results compared to tests carried out 
under controlled conditions in the laboratory.  
Analyses revealed there was only a moderate agreement between test 
conditions regardless whether the full 10 µl target sample was achieved in the 
field or not. The stochastic conditions present in the field may affect the 
performance of the test. Samples are more likely to be contaminated when 
taken in the field due to the surrounding environmental conditions. Dilution of 
the sample due to contaminants may result in a lower concentration of 
antibodies and it is unknown what direct effect the contaminants may have on 
the VetTB test. Another consideration is regarding the VetTB method which 
requires the test to be carried out at a temperature of 18 to 30oC on a flat 
surface and interpreted in well-lit conditions (Chembio Diagnostic Systems, 
2012) as found in the laboratory. When conducting tests at trap-side it is 
unlikely that the temperature would have been 18oC or higher especially during 
the colder months (January) where temperatures where likely <10oC. It is 
unknown what effect this may have had on the test and without a record of the 
temperature this aspect could not be explored in detail. Due to the nature of the 
terrain finding a flat level surface to carry out the test was difficult potentially 
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affecting the flow of sample and diluent along the cassette. A wooded overhead 
canopy coupled with low light levels in the early mornings could also affect test 
interpretation.   
Regardless of the low level of agreement between methods it was apparent 
when looking at the related RLU values (Figure 19) that any animals with a 
strong positive response were picked out in both the field and laboratory and 
therefore animals at more advanced stages of disease are likely to be detected 
in both scenarios. This would imply that the VetTB test could be used as a 
simple tool to detect badgers at advanced stages of disease. When determining 
the accuracy of the two test conditions against other imperfect diagnostic tests a 
significant difference was only found when using the IFNᵧ as reference. The 
IFNᵧ is more sensitive than both the culture and the StatPak therefore more 
indicative of the badger’s true infection status compared to the other less 
sensitive tests. With this is mind, results show that tests carried out in the 
controlled conditions of the laboratory under the manufacturers 
recommendations are significantly more accurate than those carried out in the 
stochastic conditions of the field.    
In conclusion we have developed a technique for collecting capillary blood from 
the hind paw of an unanaesthetised badger and applying it to a serological test 
in the field. With only a moderate agreement between tests carried out in the 
field and laboratory, further ways to replicate laboratory conditions should be 
considered. A way to create a level surface within a temperature controlled 
environment with an overhead light may help enhance test accuracy. In addition 
improvements in the quality of blood sample collected may be achieved by 
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sourcing a 10 µl volume heparinised capillary tube with the same bore width as 
the 5 µl one successfully trialled. This would prevent the need for two samples 
to be taken and therefore reducing the likelihood of the blood clotting. Warming 
the target area prior to incision may help increase blood flow making the blood 
more easily accessible for collection. The sensitivity and specificity of the VetTB 
test needs to be evaluated to determine if it would be sufficiently sensitive for 
routine TB surveillance. The sensitivity may also be explored against animals 
with more severe TB as a higher sensitivity in these animals would mean that 
the VetTB test could be used to remove badgers at more advanced stages of 
disease that are more likely infectious.  
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CHAPTER 4  General Discussion 
Diagnosing disease in wildlife can be more challenging than in domestic 
animals and humans. Many routine diagnostic tests have been developed for 
use in detecting or confirming disease in domestic species and have not been 
validated for use in wildlife. Wild animals are subject to a wide range of genetic 
and environmental factors many of which may influence their immune response 
such as genetic variability, history of infection (immune memory, current 
infections), physiological condition (e.g. sex, age, reproductive state and 
history), resource availability (e.g. diet), abiotic conditions (e.g. seasonality and 
temperature) and co-evolutionary history between host and pathogen 
(Pederson and Babayan, 2011).  These additional pressures may affect the 
immune system in different ways and within a group of animals, individuals will 
vary in their immune responses, some may have a strong response and others 
weak. In Chapter 2 I provide evidence of between-individual variation in the cell-
mediated immune responses of free-living badgers to a range of intrinsic 
factors. Results showed both augmentation and suppression of the general 
immune response.  My analysis also revealed factors that augment the specific 
M. bovis response. Clearly, incorporation of knowledge of these intrinsic factors 
into diagnostic determination of the bTB infection status has potential to 
improve test performance, by controlling for variation in test outcomes that does 
not arise from infection status.     
In the last few decades increased awareness of the role of wild animals in the 
maintenance and spread of important zoonotic infections means that research 
has been directed into development of specific diagnostic tests aimed at wildlife. 
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Bovine tuberculosis (bTB) is one such example where a variety of different tests 
are available for badger bTB diagnostics. Diagnostic tests are used to 
determine whether an individual is disease free, infected or has previously been 
exposed to a specific pathogen. Tests that detect the pathogen, such as culture 
and PCR show similar results in both wildlife and domestic animals (Bengis et 
al., 2002). However due to intermittent shedding of bacteria and low test 
sensitivity of culture (8%) there is a high chance that infected individuals are 
missed. Culture also takes several weeks for a result and would be impractical 
for use in a bTB control programme. Indirect tests that detect exposure to a 
specific pathogen usually measure some aspect of the animal’s immune 
response and are more variable between wild and domestic animals. The 
gamma interferon test is highly sensitive and specific but labour intensive and 
requires specialist laboratory facilities. This test would therefore not be a 
financially viable or practical option for use in a disease control programme. 
Serological tests such as the StatPak and VetTB assays are a much more 
attractive option with regard to practicality and cost, the StatPak however only 
has a moderate sensitivity and it would be questionable as to whether it would 
be sufficient to use in a control programme and has now been discontinued by 
the manufacturer. The VetTB assay to date has not yet been fully evaluated. 
The sensitivity and specificity of a test is important especially when there is a 
possibility of use within a disease control programme. Low sensitivity means 
that there is an increased likelihood of false negative results and infected 
animals may remain in the population. Low specificity, on the other hand, 
means that there is an increased likelihood of a false positive result potentially 
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causing unnecessary removal of non-infected animals, which has further 
welfare and cost implications.  
In Chapter 3 I have shown the importance of environmental conditions and 
blood quality on test performance. Diagnostic tests are usually developed in the 
controlled conditions of a laboratory, as indicated in the manufacturer’s 
methods, and are implemented by specialist personnel. These conditions are 
not easily replicated in the field and in some cases unrealistic. Blood collection 
from an unanaesthetised animal provides more challenges and collecting an 
aseptic blood sample as you would in an animal under anaesthesia is unlikely. 
Although the effects of these factors on test performance aren’t readily 
distinguished, we have shown that when using the VetTB assay in the field 
there is a negative effect on test accuracy. To try and improve accuracy it is 
important that the environmental conditions are replicated as much as possible 
to reflect the laboratory when testing in the field. The results of the diagnostic 
assay used in this study were recorded both qualitatively as a binary outcome 
(negative/positive) and quantitatively as reflectance light units (RLU). Due to the 
difference found in test accuracy, use of the RLU may be a preferred option as 
a lower cut-off value could be applied to samples tested in the field. This 
highlights the wider advantage of diagnostic tests having a quantitative output, 
compared to a visual positive/negative result based on an operator’s opinion. 
Although the VetTB assay showed a reduction in accuracy when used under 
field conditions the potential for its use as a tool to detect individuals at more 
advanced stages of diseases means that it holds potential as a tool for use in 
bTB control programmes where removing animals that are likely to shed M. 
bovis is a desired option.  
 125 
 
Surveillance of wild animal diseases that spread to domestic animals and 
humans is important, and in the case of bTB, essential to aid in the control of 
disease spreading to livestock. The development of practical, sensitive and 
specific diagnostic tests for use in badgers would enable a better understanding 
of the geographical spread of bTB infection in badgers. A non-invasive blood 
sampling device used alongside a test that identifies an infected badger could 
mean that future interventions are targeted at individual badgers or setts, rather 
than the whole population (DEFRA, 2015). In principle, removal of infectious 
individuals reduces transmission of disease within and between-species and 
limits environmental contamination. In addition the removal of all animals from a 
sett designated as infected by the presence of one or more infected animals 
could further reduce the likelihood of transmission. However previous culling 
trials have identified social perturbation amongst badger populations resulting in 
increased transmission between badgers and from badgers to cattle in adjacent 
areas (Woodroffe et al., 2006). The removal of fewer animals might be expected 
to reduce the level of disruption caused by culling and hence these negative 
epidemiological effects (Bielby et al., 2014). 
The development of strategies to control diseases shared with wildlife are 
aimed at reducing pathogen transmission to domestic animals and humans.  In 
all disease control programmes targeting wild animals there can be a strong 
public opposition especially when non-targeted culling is introduced. At present, 
without the appropriate diagnostic tools and difficulties associated with handling 
wild animals, the only measure available to remove infected animals from a 
population is by controlling it through culling. While the only option for reducing 
the availability of susceptible animals is injecting vaccine.  In the UK there is a 
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significant public opposition to culling badgers for the control of bTB in cattle 
(White et al., 2000) and therefore a non-lethal or targeted cull option may be 
more socially and politically attractive such as vaccination or a test 
vaccinate/remove option (Bielby et al., 2014).  
The recognition of bTB as a global threat at the wildlife-livestock-human 
interface has meant that badgers alongside other wildlife species such as the 
brushtail possum (Trichosurus vulpecula) in New Zealand (Coleman and 
Cooke, 2001), white-tailed deer (Odocoileus virginianus) in the United States 
(Schmitt et al., 1997) and European wild boar (Sus scrofa) in Spain (Naranjo et 
al., 2008) have been the focus of much research with diagnostic tests 
developed specifically to diagnose bTB in these species. This however is not 
the case for many other emerging infectious diseases where the important role 
that wildlife plays in the dynamics of disease transmission has been 
increasingly recognised.   
With 60% of emerging infectious disease events in humans caused by zoonotic 
pathogens and 72% of these identified from a wildlife origin, diseases in wildlife 
represent one of the most significant growing threats to global health (Jones et 
al., 2008). With this in mind including the impact of wildlife disease on 
agricultural production, biodiversity, animal welfare and the economy it is 
becoming increasingly important to gain a deeper understanding of their role 
when considering disease management. Where knowledge of disease 
management is limited in species or diseases that have received less attention, 
more research is required through surveillance and descriptive studies 
(Gortázar et al., 2007). The availability of a suitable diagnostic test to diagnose 
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diseases in wildlife is becoming increasingly important especially when 
considering future disease management recommendations.    
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